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Abstract  
 
Haemodialysis is a lifeline therapy for patients with end stage renal disease. An 
important factor in the survival of renal dialysis patients is the surgical creation of 
vascular access. The accepted gold standard of vascular access is the autologous 
arteriovenous fistula. Unfortunately it is associated with high rates of failing to 
mature. Therefore the ability to predict arteriovenous fistula outcomes following 
surgery would change current clinical practice. 
Predictive markers of arteriovenous fistula outcomes are assessed in chapter 2 of 
the thesis. The different studies in the literature and our study have shown numerous 
contradictions and therefore no single factor was found to help acurately predict 
arteriovenous fistula maturation. In chapter 3 we assessed a multifactorial approach 
with a systematic review of the literature on predictive models of maturation. The 
review found a small number of predictive models in vascular access. The disparity 
between each study limits the development of a unified predictive model and none of 
the models are currently used in clinical practice.  
Infrared thermal imaging has been available for decades but recent development in 
technology has made it small, portable and easy to use. In Chapter 4, we proved that 
this newly available hardware is a valid, accurate and user-friendly method of 
measuring skin temperature in humans and is comparable to more traditional 
methods of thermometry. Another principal finding from our thesis is that infrared 
thermal imaging can be used to quantify reactive hyperaemia following a vascular 
occlusion test in healthy volunteers and therefore is able to quantify haemodynamic 
changes in tissue perfusion (chapter 5). 
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Finally the IRTIVA study (Chapter 6) has shown that infrared thermal imaging is a 
very useful tool in accurately predicting fistula patency and maturation. For clinical 
patency, infrared thermal imaging was found to have a positive predictive value of 
88% and a negative predictive value of 86%. For functional maturation, it was found 
to have a positive predictive value of 84%, a negative predictive value of 95%. In 
addition, it was shown to have superiority to the commonly used intra-operative 
predictor of thrill as well as other independent pre-operative patient factors.  
From the thesis, it is clear that infrared thermal imaging has a definite role in renal 
patients with vascular access. In addition, there is great potential for its use in 
patients with other conditions such as peripheral vascular disease. It could be used 
as a non invasive near patient test in monitoring of outcomes following reperfusion 
interventions, both surgical and radiological ones. It might also be used as a 
predictor of outcome following renal transplantation. Therefore this thesis will be 
followed by research projects establishing the use of infrared thermal imaging in both 
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1.1 END STAGE RENAL FAILURE  
 
Chronic kidney disease (CKD) is an important long-term condition caused by 
damage to the kidneys. It is initially without any specific symptoms and is detected 
incidentally on a routine blood test. In the later stages of the disease, patients might 
develop a number of signs and symptoms including hypertension, hyperkalaemia, 
fluid overload and anaemia. The kidney disease outcomes quality initiative (KDOQI) 
working group defined chronic kidney disease in adults as (National Kidney 
Foundation, 2002): 
• Kidney damage for ≥3 months, as defined by structural or functional 
abnormalities of the kidney, with or without decreased glomerular filtration rate 
(GFR), manifesting by either:  
o Pathological abnormalities  
o Markers of kidney damage, including abnormalities in the composition 
of blood, urine or imaging tests. 
• Decreased GFR, with or without evidence of kidney damage. 
There are multiple causes of CKD and the damage is usually irreversible (U.S. Renal 
Data System, 2005). The most common causes are listed in table 1.1. Some patients 
with the condition might require renal replacement therapy in the form of either 
dialysis or transplantation. It has recently been shown to affect an important 
proportion of the general population with a prevalence of 11% in USA and Europe 
(Coresh et al, 2003). The number of patients diagnosed with CKD is likely to 
increase over time as the general population is living longer. Also diabetes mellitus is 
becoming more prevalent and it is one of the main causes of kidney damage (U.S. 
Renal Data System, 2005). 
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Polycystic Kidney Disease 
Vasculitis 
 
Table 1.1: Causes of chronic kidney disease 
 
The stages of CKD are based on the measured or estimated glomerular filtration rate 
(GFR) a measure of kidney function (Table 1.2). There are five stages including 
stage 1 where kidney function is normal (U.S. Renal Data System, 2005). The 
stages of CKD are useful tool for physician and aid in describing patients renal 
failure and in planning management.  
 
STAGE GFR Description 
1 >90 Normal renal function 
2 60-90 Mildly reduced renal 
function 
3 30-60 Moderately reduced 
renal function 
4 15-30 Severely reduced renal 
function 
5 <15 End stage renal failure 
 
Table 1.2: The KDOQI stages of chronic kidney disease 
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Once a patient has reached CKD stage 5, quality of life has generally become poor 
and life expectancy considerably shortened if the condition is untreated. Through the 
use of renal replacement therapy, survival and quality of life of ESRF patients can be 
markedly improved. In one study, participants with stage 5 renal failure managed 
without dialysis had a 1-year and 2-year survival of 68 and 47%, whilst those 
patients who chose to have dialysis had survivals of 84 and 76% respectively. 
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1.2 RENAL REPLACEMENT THERAPY  
 
Renal replacement therapy (RRT) is provided to patients in end stage renal failure. It 
has been shown to both prolong survival and improve quality of life for these patients 
(Alldredge et al, 2004). RRT can take the form of haemodialysis (HD), peritoneal 
dialysis (PD) or renal transplantation. Over the last 15 years, the number of patients 










Figure 1.1: Growth in prevalent patients by treatment modality at the end of each 
year 1997–2013: UK renal registry data (Rao A., Casula A. and Castledine C., 2015) 
 
The basic principle of haemodialysis is that it allows the diffusion of solutes across a 
semipermeable membrane by using a counter current flow. To achieve this, blood is 
diverted into a dialyser.  In the machine, the dialysate fluid is flowing in the opposite 
direction to blood flow in the extracorporeal circuit. This counter-current flow 
maintains the concentration gradient across the membrane and increases the 
efficiency of the dialysis. Urea and other waste products such as potassium diffuse 
into the dialysis solution. However concentrations of sodium and other electrolytes 
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are similar to those of normal plasma to prevent any loss. Haemodialysis was first 
performed on an uraemic patient in 1924 at the university of Glessen in Germany 
(Haas, 1925). The radial and carotid arteries as well as the portal vein were 
cannulated for the procedure. Over the following 30 years, there were numerous 
improvements made to the dialysate fluid and machines used for HD. A significant 
and major advance in vascular access occurred in the 1960s when a nephrologist 
Cimino recalled his experience of traumatic arteriovenous fistulas in Korean war 
veterans and the ability for them to be needled regularly without any complications 
(Brescia et al, 1966). He worked closely with Brescia and Appell and the first 
arteriovenous fistula (AVF) was created. This new type of vascular access became 
very popular due to its longevity and safety. To this day AVFs are the most 
commonly used vascular access around the world and the gold standard. 
Peritoneal dialysis involves the use of the peritoneum as a membrane across which 
fluids and substances are exchanged from plasma. A peritoneal catheter is placed 
surgically into the abdominal cavity to allow exchanges of dialysis fluid. There are 
two different types of peritoneal dialysis available: continuous ambulatory peritoneal 
dialysis (CAPD) and automated peritoneal dialysis (APD). As described by its name, 
CAPD is continuous and ambulatory. Dialysis fluid is inserted into the abdominal 
cavity and left there for four hours at a time to allow waste products to diffuse into it. 
This is repeated four times a day. APD involves the use of a machine and takes 
place at night for 8 to 10 hours. The dialysis solution is automatically delivered and 
drained from the abdominal cavity. Ganter was the first to use peritoneal lavage to 
treat renal failure in a patient with obstructive uropathy in 1923 (Ganter, 1923). The 
introduction of a safe and permanent catheter by Tenckhoff in 1968 in addition to the 
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novel concept of continuous dialysis in the 1970s resulted in the emergence of 
peritoneal dialysis as a viable renal replacement option (Tenckhoff and Curtis, 1970). 
Renal transplantation is another option for patients in end stage renal failure. 
Following transplantation experiments on animals in the early part of the 20th 
century, the first human kidney transplant was carried out by Voronoy in 1933 
(Voronoy, 1933). Unfortunately the kidney was blood group incompatible and the 
patient died 48 hours after the transplant. As seen with this patient, the main 
obstacle to transplantation was immunological with high risk of rejection. This 
improved with the introduction of immunosuppressive therapies in the 1960s, which 
allowed for improved rate of successful renal transplantations and long-term results 
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1.3 TYPES OF HAEMODIALYSIS VASCULAR ACCESS 
 
Arterio-venous fistula (AVF) 
An AVF is a surgically created connection between an artery and a vein, forming a 
high flow low resistance system allowing blood flow from the artery to the vein. As 
the vein adapts to the change in haemodynamics, the proximal vein becomes wider, 
more prominent and thick walled which facilitates repetitive cannulation for 
haemodialysis. This process called maturation can take up to 10 weeks to happen 
following AVF creation and therefore careful planning is required to ensure AVF 
formation is carried out prior to requiring haemodialysis (Wilmink et al, 2016). 
Nephrologist Cimino first described the concept of the AVF and its use as access for 
HD. Whilst working closely with fellow nephrologist Brescia and surgeon Appell, the 
first arteriovenous fistula was created 50 years ago (Brescia et al, 1966). 
For practical purposes, AVF creation is normally conducted on the non-dominant 
arm to allow patients to be able to use their dominant hand during haemodialysis 
sessions. To preserve as many future access options as possible, guidelines 
recommend that the most distal AVF possible should be created in the first place 
(Navuluri and Regalado, 2009). Generally there are three forearm options available 
for the creation of an AVF: snuffbox, radio-cephalic and ulnar-basilic. The snuffbox 
fistula, created between the radial artery and the cephalic vein in the anatomical 
snuffbox of the hand is the most distal site and therefore gives a long segment of 
vein for needling. It preserves proximal vessels for creation of a further AV fistula in 
the case of failure, however the procedure is technically challenging and 
anatomically variable being feasible in only 50% of patients (Wolowczyk et al, 2000). 
The radio-cephalic fistula, formed between the radial artery and the cephalic vein at 
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the wrist is the most commonly created AVF and has shown to have good long-term 
outcomes. Whilst some authors have advocated the creation of ulnar-basilic fistulas, 
between the ulnar artery at the medial aspect of the wrist and the accompanying 
basilica vein, and despite its popularity in France, it has not gained recognition 
worldwide and remains a rarely performed AVF. The Gracz fistula is a proximal 
forearm arteriovenous fistula involving an end-to-side anastomosis between a 
perforating branch of the cephalic or median antecubital vein and the proximal radial 
artery.  
If a forearm AVF is not a viable option, a brachiocephalic fistula, between the 
brachial artery and the cephalic vein in the antecubital fossa, is most commonly 
used. Brachiobasilic AVF formation is more challenging for the surgeon as it requires 
mobilisation and superficialisation of the basilic vein to make it more superficial for 
future needling. This can be done as a single procedure, joining the basilic vein to 
the brachial artery at the elbow and mobilizing the upper arm basilica vein or more 
commonly as a two-stage procedure whereby the basilic vein is anastomosed in first 
instance followed by superficialisation in the second stage following maturation of the 
vein. 
 
Arterio-venous graft (AVG) 
Arterio-venous grafts are used as an alternative when AVF formation is not feasible. 
They can be made of synthetic material such as polytetrafluoroethylene (PTFE) or 
biological material.  
First described by Soyer in 1972, PTFE is a flexible and biocompatible material that 
may be repeatedly cannulated yet maintain its structural strength (Soyer et al, 1972). 
Interestingly a patent dispute for the graft took over 40 years to be settled. Peter 
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Cooper, a Gore employee, initiated and managed an experimental investigation on 
the suitability of expanded PTFE as a graft material. Goldfarb, a cardiologist at the 
Arizona Heart Institute, was among those who received the grafts from Gore for 
experimental testing and he altered the graft to make it suitable for human use. A 
dispute ensued and after over four decades, Goldfarb was finally awarded the 
patent.  
The PTFE graft has become the most commonly used graft material. Whilst 
advances in synthetic grafts have occurred, most of these are adaptations on a basic 
expanded polytetrafluoroethylene (ePTFE) graft. Even though they do not require a 
maturation period, AVGs have traditionally not been cannulated within two weeks of 
placement but the current evidence does not support this established practice (Al 
Shakarchi and Inston, 2015). However new generation AVG have been reported as 
having self-sealing properties which allows early cannulation. They have been 
proven to allow safe early cannulation whilst having similar long-term patency results 
as standard ePTFE (Al Shakarchi, Houston and Inston, 2015).  
Biological grafts have also been considered as haemodialysis conduits and these 
can be classified according to their origin. Those derived from patients themselves 
are called autografts, from human donors homografts (=allograft) and from non-
human species xenografts. Autograft is when a vein is used in a heterotopic position, 
for example the saphenous vein has been used as a conduit in the arm. Homografts 
and xenografts have also been used but so far none have shown better results than 
ePTFE (Inston, 2015). However biological grafts may be useful in patients with high 
risk of infection (Al Shakarchi et al, 2016a).  
Different anatomical variations can be used to form an arteriovenous graft. In the 
arm, the possible sites are in both the forearm and upper arm. These include a  
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straight radiocephalic, a loop brachiocephalic or a straight brachioaxillary AVG. 
Lower extremities can also be used for placing straight or loop grafts. Other unusual 
and rarely used placements are necklace grafts and grafts between lower and upper 
limbs such as a femoro-axillary AVG (Morsy, Khan and Chemla, 2008). 
 
Tunnelled dialysis catheter (TDC) 
Tunnelled dialysis catheters (TDC) are an option for vascular access, with the 
advantages of ease of insertion and immediate use. However they should only be 
used short term due to the high rate of both morbidity and mortality (Taylor et al, 
2008). Shaldon was the first clinician to use catheters for haemodialysis and used a 
seldinger technique to insert them (Smith, 1967). Polyurethane and silicone are the 
two materials most commonly used in the manufacture of TDCs. These materials 
provide flexibility, durability and biocompatibility for intravascular use. Multiple 
designs are available but little evidence to support one over another is available. 
TDCs are used temporarily to provide vascular access whilst the patient awaits 
creation and maturation of an AVF or AVG. They can also be used when patients 
have run out of suitable options for permanent vascular access. 
Until the 1990s, catheters were placed in subclavian veins but the site was found to 
cause a high rate of central vein stenosis. Thereafter insertion into the jugular vein 
has become standard practice although the femoral vein can also be used. In end 
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Vascular Access type by country 
Internationally, there is wide variation in the type of vascular access used. Japan has 
a high AVF use (>90%), whilst Canada’s AVF use is below 50% (Figure 1.2). As 
demonstrated by DOPPS data, such variation in haemodialysis practice has 
undoubtedly an effect in long term patient outcomes and this is the reason why most 
countries have changed their policies and guidelines to increase the rate of AVF use. 
However survival outcome with access type is not consistent and variation in multiple 
factors must be considered when analyzing data. For example, conclusions made 
from Japanese HD patients are subject to substantially more uncertainty than that for 
U.S. patients due to both smaller sample size and lower event rate. 
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1.4 COMPLICATIONS OF HAEMODIALYSIS VASCULAR ACCESS 
 
Early failure/Late failure (non-maturation) 
As previously mentioned, AVF is the first choice vascular access. However a 
significant number of fistulas (up to 50%) fail to adequately support haemodialysis 
following creation due to early failure or non-maturation (Dember et al, 2008). Early 
failure is defined by immediate failure of AVF within 72h of surgery due to 
thrombosis. The likely causes for this are surgical technique, poor arterial inflow or 
venous intimal fibrosis. An arteriovenous fistula needs to go through a maturation 
period before it can be used for dialysis. Maturation simply implies the fistula has 
dilated, become more prominent and thick walled which allows repetitive cannulation 
for haemodialysis. 	  
Definitions of maturation are multiple. The rule of the 6s describes an easy method 
to assess AVF maturation at 6 weeks (National Kidney Foundation, 2006): 
1. an adequate diameter (> 6 mm) 
2. adequate access flow rate (~600 ml/min)  
3. sufficiently superficial (<0.6 cm deep) 
Other definitions include successful 2-needle cannulation of the AVF for dialysis. 
Unfortunately late failure (non-maturation) is an important complication of AVF 
formation (Dember et al, 2008). Creation of an arteriovenous fistula involves the 
surgical anastomosis of a high-pressure artery to a low-pressure venous system. 
Most of the arterial blood flow diverts into the vein as a result of low resistance. 
Adequate perfusion of the tissue distal to the fistula requires sufficient dilatation of 
the proximal arterial system and increase in cardiac output to compensate for the 
diversion of blood flow through the fistula. Normal brachial arterial blood flow is 50 
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ml/min with radial blood flow rates of around 25 ml/min (Wedgwood, Wiggins and 
Guillou, 1984). A successful AVF will normally have a blood flow of at least 
500ml/min, therefore the artery flow must increase at least 10-20 fold in order to 
deliver adequate blood flow and achieve AVF maturation. Therefore substantial 
arterial dilatation and remodeling is required for successful fistula maturation. 
However in most cases, the arterial flow does not increase sufficiently to allow 
maturation and therefore retrograde blood flow (also known as physiological steal) in 
the distal artery occurs. If the steal is severe, it can lead to tissue ischaemia (Dixon, 
2006). However most patients are asymptomatic due to collateral arteries which 
reconstiture below the AVF therefore maintaining distal perfusion (Inston et al, 2017). 
The increased blood flow in the vein following AVF creation also causes an increase 
in wall shear stress (WSS), which leads to venous wall thickening and arterialization 
(Hammes, 2015). Normally the luminal diameter will increase in an attempt to reduce 
the WSS back to pre-AVF levels resulting in a dilated vein with a thickened wall, the 
perfect vessel to use for hemodialysis (Hammes, 2015). This flow-mediated 
dilatation occurs via endothelial-mediated responses such as the release of nitric 
oxide and other endothelium-dependent vasodilators (Corpataux et al, 2002) 
Causes of non-maturation range from poor arterial inflow (inadequate vessel 
diameter, atherosclerotic disease, anastomosis of small size, chronic hypotension), 
post-anastomotic vein stenosis (possibly due to clamping damage), lack of ligation of 
tributary veins and venous fibrosis secondary to trauma from previous needling.  
 
Vascular Access Stenosis 
Vascular access stenosis can develop at any site along the AVF/AVG and can be 
described mostly anatomically with: anastomotic, post-anastomotic, puncture-related 
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or venous outflow. The diagnosis of vascular access stenosis can be accurately 
done in the majority of arteriovenous fistulas by physical examination alone. Imaging 
such as ultrasonography or fistulography can be used to confirm the clinical 
suspicion and define morphology.  
The aetiology of VA stenoses is: 
§ Surgical - anastomotic stenosis 
§ Clamp damage - post-anastomotic 
§ Neointimal hyperplasia - post-anastomotic and venous outflow. 
§ Puncture technique - puncture related stenosis 
Surgical anastamotic stenosis may occur where the anastamosis has been created 
too tightly although as the anastomosis is a fixed size it may be a relative stenosis as 
maturation occurs the adjacent vessel distends. In low flow situations this may be 
regarded as a stenosis but if high flow occurs within the AVF this simply represents a 
flow controlling area and should not be treated. 
Neointimal hyperplasia has been the subject of extensive research to improve 
AVF/AVG patency rates (Roy-Chaudhury, 2007). Research has been focused on 
how to inhibit the two main pathological factors involved in the development of this 
complication: shear stress and endothelial cell proliferation. Shear stress has been 
proven to be the main cause of neointimal proliferation by experimental flow models 
(Lee and Roy-Chaudhury, 2009). 
Management of stenotic lesions is either surgical or endovascular (balloon dilatation 
or stent placement).  The KDOQI Guidelines recommend that stenoses should be 
treated with angioplasty or surgical revision if the stenosis is >50% of the lumen 
diameter and is associated with any clinical abnormality such as prolonged post-
dialysis bleeding or difficulties in cannulation (National Kidney Foundation, 2006). 
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Central Vein Stenosis 
Central vein stenosis is commonly associated with placement of central venous 
catheters and other devices (eg. pacemaker wires). Risk factors for stenosis 
development are a history of multiple catheters, long duration of catheter use, 
insertion in the subclavian vein and placement on the left-hand side of neck 
(Agarwal, Patel and Haddad, 2007). Endothelial injury with subsequent changes in 
the vessel wall results in development of micro-thrombi, smooth muscle proliferation, 
and central vein stenosis. Central vein stenosis can be asymptomatic and present 
with oedema of the ipsilateral upper limb following vascular access formation due to 
the increased flow (Agarwal, 2015). They are also a known factor for failure to 
mature following AVF formation. Endovascular interventions are the mainstay of 
management of central vein stenosis. Percutaneous angioplasty and stent 
placement can restore the functionality of the vascular access. Frequent or multiple 
interventions are usually required to keep the central vein patent (Maya, Saddekni 
and Allon, 2007). Studies on the mechanisms of development of central vein 
stenosis has led to the development of drug eluting balloon angioplasty which might 
improve outcome following intervention (Massmann et al, 2015). Prevention of 
central vein stenosis is the key to avoid access failure and other complications from 
central vein stenosis and relies upon avoidance of central vein stenosis placement 
and timely placement of arteriovenous fistula in prospective dialysis patient.  
The HeRO graft is a new solution to this difficult problem (Al Shakarchi et al, 2015). It 
consists of two elements: an arteriovenous graft and a venous outflow component. 
The venous component is inserted percutaneously straight into the right atrium 
bypassing any central stenosis. The arteriovenous graft is anastomosed to the 
ipsilateral brachial artery and the two components are connected together using a 
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specially made titanium connector. 
 
Vascular Access Infection 
Infection is a serious complication of dialysis vascular access, which has an 
important impact on both access outcome and patient survival. Infection can develop 
at puncture sites due to poor aseptic technique or haematoma formation. Therefore 
infection prevention is critical for vascular access maintenance by strict adherence to 
aseptic and antiseptic protocols by the nursing staff (Grabe, Jakobsen and Damm, 
1985).  
AVF or AVG infection should always be managed as an emergency condition that 
requires hospitalisation since it can lead to rupture with bleeding or sepsis. 
Aggressive empirical antibiotic therapy should be started immediately on admission 
until culture results are available (Ryan, Calligaro and Dougherty, 2004). Removal of 
an infected AVG may be required as antibiotics have poor infiltration to foreign 
materials. This will usually involve inserting and using a temporary central dialysis 
catheter whilst creating a new vascular access at a different site. 
 
ArterioVenous Access Ischaemic Steal (AVAIS) 
Also referred to as dialysis associated steal syndrome (DASS) or haemodialysis 
access induced distal ischaemia (HAIDI), it occurs in up to 8% of patients (Beathard 
and Spergel, 2013). As previously explained, haemodynamic changes occur in the 
arm following AVF creation, which lead to physiological steal. If collateral vessels are 
poor or there is proximal arterial disease, clinical steal will occur and patients will be 
symptomatic. Clinical steal can be subdivided into early (<1month) or late (>1month) 
depending on the time of onset of symptoms. Early clinical steal is more often seen 
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in AVG whilst late clinical steal is usually seen in AVF. The reason for this is that 
AVF require a maturation process with venous diameter and flow rate increasing 
over time, whereas AVG have a set diameter which will lead to an immediate 
increase in flow rate. 
Following the creation of upper limb vascular access, patients may develop a cold 
painful hand with neurological deficits or in extreme cases distal gangrene and 
ulceration. The incidence is higher in upper arm arteriovenous fistulas and grafts 
than in forearm vascular access due to the single arterial supply (Tordoir, Dammers 
and Van Der Sande, 2004). Risk factors for AVAIS are diabetes and peripheral 
vascular disease. Clinically AVAIS is similar to that of peripheral vascular disease 
and can be classified according to symptoms (Tordoir, Dammers and Van Der 
Sande, 2004). 
Stage I Cold/Pale hand without pain 
Stage II Pain on exertion and/or during haemodialysis 
Stage III Pain at rest 
Stage IV Ulceration/necrosis/gangrene 
The diagnosis of steal syndrome is made clinically and can be confirmed by color 
Doppler ultrasound and other complementary imaging. Management of this 
complication traditionally was ligation of the vascular access. To preserve the 
vascular access, a number of different surgical procedures have been proposed 
which include banding, revision using distal inflow (RUDI), proximalisation of access 
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Pseudoaneurysms/Aneurysms 
Pseudoaneurysms are puncture-related complications of both AVF and AVG. The 
trigger event is a traumatic cannulation during haemodialysis or an anastomotic leak 
following surgery with subsequent haematoma formation around the vessel (Valenti, 
Mistry and Stephenson, 2014). The size of the haematoma may vary widely and 
inadequate compression at puncture site favours further haematoma growth. Once 
the haematoma is formed around the fistula vein or graft, it develops a fibrotic sac 
but this is not lined by any endothelium. Ultrasound guided direct thrombin injection 
into the pseudoaneurysm sac has been used however surgical revision has been the 
standard approach to manage pseudoaneurysms (Keeling et al, 2008). 
Endovascular treatment using covered stents insertion has also been advocated to 
treat such complications. This method has proven to be both safe and effective and 
the results have been encouraging so far (Ananthakrishnan et al, 2008). 
True aneurysms are widened or enlarged segments of the arterialized vein that may 
develop at puncture site or at the anastomosis. Aneurysms may reach significant 
sizes. If they present with a rapid increase in size, pain, thinning of the overlying skin 
or infection, they should be managed emergently with ligation as they are at high risk 
of rupture (Uysal and Ceviker, 2016). In other circumstances where the aneurysm is 
slow growing, they can be managed conservatively with aesthetic reasons being the 
main indication for surgery. Obviously in this setting, the desired outcome should be 
preservation of definitive access where possible and excision of the aneurysm with 
plication is a suitable surgical option. 
 
Heart failure 
It is an uncommon complication and occurs in high flow fistulas (Bourquelot, 2016). It 
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is generally defined as an AVF with flows over 1l/minute at the forearm and over 
1.5l/minute at the upper arm (Sequeira and Tan, 2015). It has also been described 
as access with a flow that is >20% of cardiac output (Pandeya and Lindsay, 1999). 
Although a large number of patients might not develop any symptoms, high flow 
access may lead to high output cardiac failure or pulmonary hypertension. Anaemia 
and underlying heart disease are also important pre-disposing risk factors. Surgical 
banding may relieve symptoms but in cases of persistent symptoms, ligation of the 
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1.5 PREDICTORS OF ARTERIOVENOUS FISTULA MATURATION  
 
Clinical and ultrasound assessment 
Clinical assessment has been used to choose the location of arterio-venous fistula 
formation. Assessment of venous size and arterial pulse by palpation was 
traditionally carried out pre-operatively in clinic prior to listing. Duplex 
ultrasonography has been used as an adjunct to clinical examination to assess more 
accurately the size of both artery and vein. It has been shown that a larger venous 
diameter improves maturation rate. Studies carried out previously have suggested 
that preoperative ultrasound mapping of venous diameters versus no mapping is 
beneficial, but did not reach statistical significance (Nakata et al, 2016). Utilization of 
different cut off values can have significant effects on maturation rates.  Therefore 
ultrasound scanning pre-operatively should be carried out on all patients and 
measurement taken to ensure that the chosen vein is of suitable diameter (Ferring, 
Henderson and Wilmink, 2014). There is also evidence that artery size has an effect 
on maturation rate and should be assessed too. Fistula site has been shown to be a 
predictor of maturation with brachiocephalic being more likely to mature than 
radiocephalic arterio-venous fistulas. However this might well be related to venous 
and arterial sizes being generally larger at the elbow than at the wrist.     
  
Demographics 
The hemodialysis fistula maturation study looked extensively at pre-operative factors 
that could predict early fistula thrombosis (Farber et al, 2016). This multicentre study 
included a large cohort of patients and looked specifically at the following 
demographic and clinical factors: gender, age, ethnicity, work status, body mass 
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index, smoking status, hypercoagulability disorder, co-morbidities, cause of renal 
failure and current maintenance haemodialysis. Interestingly despite looking so 
extensively, the only significant factor found as a predictor of early thrombosis was 
female gender (Farber et al, 2016). Of note, diabetes was found to be inversely 
associated with early thrombosis, even when adjusted for potential cofounders. 
 
Blood biomarkers 
Blood biomarkers have been found to be predictive in numerous medical conditions. 
The use of biomarkers in the diagnosis and management of cardiovascular disease, 
infections and cancer are well established in current practice (Mayeux et al, 2004). 
As yet there has been no single blood biomarkers identified as a useful predictor to 
AVF maturation. While routine ultrasound screening may improve AVF survival rates 
by allowing early identification of fistulas at risk of failure, this is time and labour 
intensive. In contrast, the detection of blood biomarkers might allow a more cost 
effective way to identify patients at higher risk of AVF failure. Few studies have 
assessed the relationship between blood biomarkers (eg. soluble e-selectin) and 
AVF failure and there is discrepancy between the conclusions reported (Kirkpantur et 
al, 2008; Bilgic et al, 2015). A lot of these studies also focused on a small number of 
biomarkers (eg. Osteoprotegerin, red blood cell distribution) and included a relatively 
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1.6 BASICS OF INFRARED THERMAL IMAGING  
The electromagnetic spectrum contains an array of electromagnetic waves with a 
range of frequency and wavelength. Visible light is a small part of that radiation 
distribution but the only one that the human eye can discriminate. On the higher 
frequency side of the electromagnetic spectrum, we can find the ultraviolet waves, 
the x-rays and the Gamma rays whilst on the lower frequencies we find the infrared, 
microwaves and radio waves (National Aeronautics and Space Administration, 
2016).  
 
Figure 1.3: The electromagnetic spectrum (National Aeronautics and Space 
Administration, 2016) 
 
All objects above the temperature of absolute zero (-273.15C) radiate and absorb 
energy in the form of electromagnetic radiation and the quantity of electromagnetic 
energy radiated is related to its temperature, surface area and the type of surface 
(Thomas, 1999). A perfect black body does not reflect radiation from its surface and 
absorbs 100% of the incident radiation. This makes it a perfect absorber and 
inversely it is also a perfect radiator/emitter of radiant energy. The radiative property 
of an object is expressed as emissivity, which is calculated as the ratio of energy 
emitted by an object over the energy emitted by a black body at the same 
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temperature (Thomas, 1999). Therefore emissivity value can range between 0 and 1, 
with a perfect black body having a value equal to 1. Human skin has been found to 
be an almost perfect radiator with emissivity values ranging between 0.96 and 0.98 
(Houdas and Ring, 1982). Therefore thermal radiation emitted from skin is very 
closely related to the actual skin temperature and in turn infrared thermography is 
well suited for skin temperature measurement. It has also been shown that there is 
no difference in skin emissivity based on skin colour and therefore measurements 
from thermograms are independent of ethnicity (Jones, 1998). It is important to also 
note that emissivity depends on the viewing angle as it remains constant until ~50° 
however at greater angles, the emissivity does decrease (Dozier and Warren,1982). 
Unlike a perfect black body, this is due to the fact that normal surfaces do not emit 
infrared radiation similarly in all directions. 
In 1800, astronomer William Herschel was the first to discover infrared radiation 
whilst experimenting on sunlight passing through a glass prism (Scott Barr, 1961). 
He found that IR could be reflected like visible light and detected by thermometry. 
The first ever thermogram was actually recorded by his son John Herschel in 1840. 
In the middle of the 20th century, an increase interest in the subject led to the first 
electronic sensors for the detection of IR radiation being developed (Dereniak and 
Boreman, 1996). The military industry took a vivid interest in the technology and 
adapted it to be used for night vision. Infrared thermal imaging continued during most 
of the 20th century to be used primarily for military and space applications. This led to 
the technology being improved rapidly over time. Initially acquiring a thermal image 
would be both time consuming and technically challenging with the image quality and 
resolution being generally poor. However through the development of bolometer 
cameras, the technology has now become much more advanced and user friendly 
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(Dereniak and Boreman, 1996). Infrared radiation strikes the detector 
(microbolometer), which is made of a grid of sensors over a grid of silicon, and 
changes its electrical resistance. This change is then processed into temperatures, 
which can then be used to create an image. The microbolometer is an uncooled 
thermal sensor, thus avoids the requirement of bulky expensive cooling techniques. 
Therefore these cameras have cost, size, power and reliability advantages over their 
predecessors (Wang et al, 2005). These cameras originally developed in the 1970s 
were initially restricted to military uses only until the end of the 20th century. 
Technical advances in both software and hardware have improved dramatically over 
last decade. Today’s infrared thermal imaging (IRTI) cameras are reliable, accurate, 
cost effective and considerably more portable than previously. This has happened by 
industrial and military use of the technology rather than scientific use. However 
medicine might well benefit from this as IRTI has many potential clinical uses. Even 
though it has had previous interest from clinicians and scientists, there has been a 
resurgence of clinical applications of its use, seen by a number of recently published 
papers (Ring and Ammer, 2012). 
Thermal images are actually visual displays of the amount of infrared energy 
emitted, transmitted, and reflected by an object. A thermal imaging camera is 
capable of performing algorithms to interpret that data, build an image and calculate 
the temperature. It is also important to understand the different terminologies used in 
this topic and the commission of the European Association of Thermology defined 
these (Terminology Commission of European Association of Thermology, 1978): 
• Thermology: General term for the study of the nature and effects of heat and 
thermal energy. 
• Thermometry: Measure of one parameter of the thermal state of a body, 
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which is temperature. 
• Thermography: Recording of the temperature or temperature distribution of a 
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1.7 INFRARED THERMAL IMAGING IN MEDICINE 
One of the simplest measurements taken by any clinician is a patient’s temperature 
as it is a long established indicator of health. Humans are able to maintain a constant 
temperature, as part of homeostasis to allow normal tissue function (Guyton and 
Hall, 2006). Change in the core temperature is a clear sign of bodily dysfunction. 
Body temperature has traditionally been measured using a thermometer, however 
IRTI has also been used, mainly for research purposes for over 50 years. It has been 
used to study numerous medical conditions where skin temperature can reflect the 
presence of inflammation in the underlying tissues, or where blood flow has changed 
due to a clinical abnormality. IRTI can be applied in medicine either as a screening 
tool or diagnostic test. 
 
Peripheral circulation 
In some vascular conditions, such as Raynaud’s disease, the effect of local blood 
circulation on skin temperature has been assessed by IRTI (Ammer, 2009). This was 
carried out after exposure of the hands to a temperature stimulus. In normal healthy 
subjects this leads to a reactive hyperaemia of the fingers, while in Raynaud’s 
sufferers there is a slow protracted recovery to baseline. This test has been applied, 
to allow quantification in many different studies and trials of vasodilator treatments 
(Ammer, 2009).  
A study from China has looked at the use of thermography in the diagnosis of 
suspected cases of deep vein thrombosis. Assessing this first in an animal model 
and confirming their initial findings in humans with a diagnostic concordance rate of 
96.9% (Deng et al, 2012; Deng et al 2015). They concluded that IRTI could serve as 
a novel effective detection and screening tool for DVT.  
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There have also been reports of the use of IRTI in the field of vascular access. Allen 
et al investigated the use of thermography in patients with suspected steal syndrome 
from dialysis access arteriovenous fistulas and found an agreement between its use 
and clinical assessment of steal syndrome (Allen et al, 2006). Similarly Novljan et al 
found similar results and therefore concluded that whilst the diagnosis of steal 
syndrome is primarily clinical, thermography might be a safe, non-invasive, cheap 
tool for the timely detection of at risk patients (Novljan et al, 2011). In addition 




Melanoma identification was one of the first clinical applications of infrared thermal 
imaging (Di Carlo, 1995). The value of IRTI for diagnosis of malignant melanomas 
has been a subject of controversy in the past (Maillard and Hessler, 1969; Cristofolini 
et al, 1981). However recent studies have shown that malignant and benign 
melanomas have different patterns of temperature changes (Cristofolini et al, 1981). 
The use of IRTI has been investigated in the detection of breast carcinoma. Arora et 
al investigated the use of thermography in 92 patients whom a breast biopsy had 
been recommended based on prior mammogram or ultrasound (Arora et al, 2008). 
They demonstrated that IRTI identified 58 of the 60 malignancies with a sensitivity of 
97% and a specificity of 44% and concluded that infrared thermal imaging was a 
valuable adjunct to mammography and ultrasound. Further studies in breast cancer 
(Rassiwala et al) assessed the use of IRTI as a screening tool in a study including 
1008 patients (Rassiwala et al, 2014). Based on these results, thermography was 
evaluated as a very useful tool for screening breast carcinoma as it is non-contact, 
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pain-free, radiation free and comparatively inexpensive. 
Intraoperative IRTI has been studies in neurosurgery as a novel technique to locate 
the margins of primary and metastatic brain tumors. Kateb et al have suggested that 
thermal imaging could be used to provide a rapid, non-invasive, and real-time intra-
operative imaging adjunct (Kateb et al, 2009). 
 
Inflammatory arthritis 
Rheumatoid arthritis was one of the earliest conditions where thermography was 
used clinically. Ring et al showed that the surface temperature of an arthritic joint 
closely reflected the intra-articular joint, and to other biochemical markers of 
inflammation obtained from the exudate (Ring and Collins, 1970). Collins et al 
showed that IRTI can be used for the assessment of joint involvement in 
inflammatory arthritis (Collins et al, 1974). Recently, a pilot study from the United 
States found a strong correlation between high temperature and swelling of finger 
joints detected by three-dimensional images. The authors developed a heat 
distribution index using IRTI, which had a diagnostic sensitivity of 67% and a 
specificity of 100% for arthritic swelling (Spalding et al, 2008). 
 
Soft tissue injury 
Muscle action is one of the most important sources of increased metabolic heat. 
Acute muscle injuries may be recognized by areas of increased temperature due to 
inflammation in the early state of trauma (Schmitt and Guillot, 1984). However, long 
lasting injuries and also scar tissue can appear as hypothermic areas due to reduced 
muscle contraction, and therefore reduced heat production. Similar areas of reduced 
temperature have been found adjacent to peripheral joints with a decreased range of 
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movement due to inflammation or pain (Ammer, 1995). Silva et al assessed the use 
of IRTI in paediatric patients and found that although suboptimal, performance in 
finding the site of injury was encouraging and should be further evaluated (Silva et 
al, 2012). Yang et al proved that IRTI can show temperature changes in ligamentous 
injury and can be applied in the evaluation of medial collateral ligament injuries 
(Yang et al, 2014). 
 
Burns & Plastic Surgery 
Reports by Cole et al in the 1990s showed promise for the use of IRTI in the 
assessment of burns (Cole, Jones and Shakespeare, 1990; Cole et al, 1991) and 
more recently a British group aimed to investigate the use of thermography in the 
assessment of burn depth (Hardwicke et al, 2013). Eleven patients with burns 
affecting different parts of the body were included in this study that found that 
thermal imaging could determine differences in burn depth. 
In reconstructive surgery, De Weerd et al have shown that the design of deep inferior 
epigastric artery perforator flaps, which are used for breast reconstruction, can be 
based on dynamic infrared thermal imaging for pre-surgical selection of the vessel 
(De Weerd, Mercer and Setsa, 2006). The same group of researchers also showed 
IRTI to be a valuable tool for both intra-operative and post-operative monitoring in 
flap surgery (De Weerd, Weum and Mercer, 2009; De Weerd, Miland and Mercer, 
2009). Thermography has recently been shown to be a quick, easy method of 
assessing cutaneous perforators. It should be considered a useful adjunct, and 
further investigated, to determine its best role among the established perforator 
imaging methods (Sheena et al, 2013). 
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Diabetes 
Sivanandam et al investigated the potential of IRTI in diagnosing as well as 
predicting type 2 diabetes compared with biochemical assay of HbA1c as standard 
(Sivanandam et al, 2012). They found that diabetic patients had lower cutaneous 
temperature at various anatomical sites compared to healthy individuals. Palmar 
temperature could be used for diabetes diagnosis (threshold <33.85 degrees) with 
sensitivity of 90% and specificity of 56%. They also found that as HbA1c increases, 
skin temperature decreases. They then concluded that thermography could be used 
as a diagnostic as well as prognostic tool for diabetes. 
Van Netten et al also explored the use of IRTI in diabetes, in particular in detecting 
diabetic foot problems and found that areas with complications had a significant 
lower temperature than the rest of the foot or when compared to the contralateral 
side (Van Netten et al, 2013).  
 
Renal Transplantation 
There have been reports of the use of infrared thermal imaging during renal 
transplantation. Gorbach et al investigated the use of IRTI in 13 transplanted patients 
and found that renal rewarming time as determined by thermography correlated with 
cold ischaemic time (Gorbach et al, 2003). They also found that it could predict 
return of renal function. 
 
Surgical site infection 
A Japanese plastic surgery group presented a case report of the use of IRTI in 
screening for post operative infection following the Nuss procedure (minimally 
invasive procedure to treat pectus excavatum) and found that Infrared thermography 
	   49 
camera clearly indicated slight cellulitis in the right chest (Fujita et al, 2013). 
 
Evidence of diagnostic use of IRTI in cancers, peripheral vascular and 
musculoskeletal conditions demonstrates value in pursuing further studies in this 
technology. 
The data to date is from single centre studies involving a small number of subjects 
and as such do not represent a driver for clinical change and is important to not 
overstate the clinical uses of thermography until more robust studies are performed.  
Despite this the technology is available, cheap, non invasive and can be used with 
minimal training in all areas of healthcare delivery. The results are produced in real 
time and can be transmitted easily by electronic means.  
In conclusion there is great potential in the use of infrared thermal imaging in 


















Predictive markers of arteriovenous fistula 
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2.1 ABSTRACT 
 
Native Arteriovenous fistulas are the gold standard for haemodialysis vascular 
access. Unfortunately they have a high rate of failure to mature. In this study we aim 
to assess different pre-operative blood and anatomical markers in predicting fistula 
maturation. 
Our prospectively collected cohort study included consecutive patients who 
underwent fistula formation for dialysis. Pre-operative markers assessed included 
systolic & diastolic blood pressure as well as numerous haematological and 
biochemical blood tests. Arterial and venous diameters were also included as 
anatomical markers. 
110 patients were included with a median age of 60 (range: 18-84). Our results 
showed that increased venous diameter was found to correlate significantly with 
improved outcome. A low haemoglobin and white cell count were also found to be 
significant positive predictive parameters. 
In conclusion our study has shown venous diameter to be a significant predictor of 
maturation. However the literature and our study have shown numerous 
contradictions regarding blood markers and therefore no single factor can help 
acurately predict arteriovenous fistula maturation. A multifactorial approach may be 
required in the form of predictive modelling, assessing a combination of blood 
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2.2 INTRODUCTION 
 
Haemodialysis (HD) is a lifeline therapy for patients with end stage renal disease 
(ESRD). It is estimated that over 1.5 million patients receive regular HD treatment 
worldwide (Grassmann et al, 2005). An important factor in the survival of renal 
dialysis patients is the surgical creation of vascular access. The accepted gold 
standard of vascular access is the autologous arteriovenous fistula (AVF). Three 
important steps are required for a fistula to successfully mature and be used for 
dialysis: venous dilatation, sufficient blood flow and the fistula must be superficial 
enough to allow needling. Unfortunately AVFs are known to be associated with non-
maturation and poor long-term patency (Nikam et al, 2012; Al-Jaishi et al, 2014). 
Early identification of fistulas at risk of non-maturation can help guide salvage 
intervention (Al-Jaishi et al, 2014). Numerous factors such as venous diameter have 
been suggested as having an effect on the success rate of maturation (Smith, Gohil 
and Chetter, 2012). 
In this study we aim to assess the prognostic role of blood tests as well as 
anatomical markers for fistula maturation. This could allow us to monitor patients at a 
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2.3 METHOD 
 
Prospective data was collected for consecutive patients with end stage renal disease 
referred at our tertiary specialist unit for single incision AVF formation under local 
anaesthetic between April and September 2009. All patients received pre-operative 
ultrasound mapping to select the most appropriate anatomical site dictated by vessel 
diameters in a specialist clinic to attempt to minimize environmental factors such as 
room temperature. Demographic and physiological data were also gathered, namely 
- sex, age and co-morbidities, grade of operating surgeon, type of AVF created 
(radio-cephalic, brachio-cephalic and brachio-basilic) and ultrasound results. The 
pre-operative blood biomarkers assessed were haemoglobin, white cell count, 
platelets, INR, CRP, cholesterol, triglyceride, urea, creatinine, phosphate, 
magnesium and folate level. Venous and arterial diameters as anatomical 
geometrics as well as systolic and diastolic blood pressure were also assessed as 
predictive markers. This cohort was followed up over 4 years until August 2013. 
Maturation was defined as ability to use the AVF for adequate dialysis on at least two 
separate occasions. The study was approved by local audit review board (CARMS-
11315) where specific patient consent was not deemed necessary as it was non-
interventional and observational.	  
 
Statistical analysis 
Collation of database and statistical analysis were carried out in SPSS release 2009 
Version 18.0, PASW Statistics for Windows SPSS Inc, Chicago. Statistical analysis 
of pre-operative markers and outcomes was undertaken using unpaired student t-
test where samples were normally distributed and Mann-Whitney U for non-normally 
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distributed data. Data are presented as mean and standard deviation (SD) (when 
data normally distributed) or median and inter-quartile range (IQR) (non-normally 
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2.4 RESULTS 
 
A total number of 110 patients underwent AVF formation and were included in the 
analysis. Their median age was 60 (range 18-84) with a female to male ratio of 2:1. 
Demographics of our cohort is described in table 2.1. The primary aetiology for the 
patients ESRD varied amongst the group. Diabetes and hypertensive nephropathy 
were the most common cause. The median follow up of patients was 50 months 
(range 3-53). 62% of our cohort successfully used their fistula for dialysis.  We did 
not find any significant difference in outcomes depending on grade of surgeon. 
 
Demographic Population n (%) 
Median Age 60y 


























Diabetes 33 (30%) 




Previous transplant 10 (9%) 
 
Table 2.1: Demographics of patient cohort for predictive markers 
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The summary of our findings are described in Table 2.2. A larger venous diameter 
was associated with a significant increase in maturation of fistulas as well as a lower 
haemoglobin and white cell count. There were trends suggesting that a lower level of 
folate and magnesium were associated with better results. However, none of these 
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Factor Functional 
maturation 
N Mean Standard 
Deviation 
P-value 
Age Yes 68 60.7 16.5 0.58 
 No 42 58.9 17.6  
Vein Diameter Yes 64 3.64 0.90 0.02 
 No 39 3.18 0.94  
Artery Diameter Yes 47 3.59 1.42 0.62 
 No 33 3.43 1.37  
Systolic BP Yes 39 149.2 31.8 0.9 
 No 27 150.1 26.4  
Diastolic BP Yes 39 79.5 13.4 0.82 
 No 27 80.2 11.3  
Haemoglobin Yes 68 11.23 1.97 0.04 
 No 42 12.07 2.29  
White cell count Yes 68 7.16 2.63 0.05 
 No 42 8.2 2.68  
Platelets Yes 68 228.7 74.6 0.74 
 No 42 224.1 62.0  
INR Yes 64 1.10 0.25 0.01 
 No 39 0.99 0.09  
Cholesterol Yes 65 4.44 1.43 0.88 
 No 39 4.47 1.32  
Triglyceride Yes 63 1.94 1.15 0.74 
 No 36 1.85 1.24  
Urea Yes 68 17.62 8.80 0.95 
 No 42 17.73 9.65  
Creatinine Yes 68 495.93 238.01 0.20 
 No 42 442.05 171.89  
Phosphate Yes 46 1.54 0.44 0.83 
 No 32 1.56 0.40  
Magnesium Yes 35 0.94 0.13 0.06 
 No 25 1.01 0.14  
Folate Yes 48 7.68 4.92 0.23 
 No 32 9.12 5.74  
CRP Yes 61 16.1 32.4 0.54 
 No 34 20.3 30.3  
 
Table 2.2: Summary of the predictive accuracy of anatomical and blood markers  
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2.5 DISCUSSION 
 
AVF maturation has been a difficult problem to deal with for clinicians worldwide. 
Many factors can have an effect in the success or failure of an AVF. We found a 
significant difference in outcome depending on the venous diameter. A larger 
intraluminal diameter of a vein was associated with a higher functional maturation 
rate. Studies carried out previously have suggested that preoperative ultrasound 
mapping of venous diameters versus no mapping is beneficial, but did not reach 
statistical significance (Wong et al, 2013). Utilization of different cut off values can 
have significant effects on maturation rates.  Ultrasound scanning pre-operatively 
should be carried out on all patients and measurement taken to ensure that the 
chosen vein is of suitable diameter (Wong et al, 2013).    
We did not find any significance to folate level.  This is an interesting finding as 
Righetti et al had suggested that folic acid supplement was associated with an 
improvement in results of primary patency rate in fistula in a small cohort of patients 
(Righetti et al, 2009). However folic acid supplementation whilst on HD has been 
investigated in relation to cardiovascular events in patients with ESRD and does not 
appear to have any effect on venous access thrombosis (Wrone at al, 2004).  
In our study, patients with a lower haemoglobin had better maturation rates which 
confirms the finding from a recently published study (Bashar et al, 2015). The low 
haemoglobin has been hypothesized to lead to upregulation of endothelial nitric 
oxide synthase leading to vasodilation, however this is yet to be confirmed by further 
studies (Bashar et al, 2015).  However this is contradictory to previous evidence, 
which showed that haemoglobin level did not have an effect on outcome (Khavanin 
Zadeh, Gholipour and Hadipour, 2008). The better outcome associated with a lower 
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white cell count in our study contradicts other evidence in the literature (Bashar et al, 
2015). 
There was no difference in cholesterol level between the two patient groups 
(maturing vs non maturing). This explains the recent study from Birch et al which 
found that statin therapy did not decrease the number of stenotic lesions developing 
in AV fistulas. (Birch, Fillaus and Florescu, 2013).  
Limitations of the study were the missing data from medical records as there was no 
pre-operative protocol for the blood tests. It is important to mention that unlike 
previous studies, we assessed functional maturation as defined by the ability to use 
the AVF for adequate dialysis on at least two separate occasions. It might mean that 
some patients whose renal function was stable and did not require haemodialysis 
were deemed as non-mature. 
In conclusion the literature and our study have shown numerous contradictions and 
therefore no single factor was found to help acurately predict arteriovenous fistula 
maturation apart from venous diameter. Hence, predictive markers have not made it 
into routine clinical practice, however a minimum venous diameter of 2mm has been 
advocated (Smith, Gohil and Chetter, 2012). A multifactorial approach may be 
required in the form of predictive modelling, assessing a combination of blood 
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3.1 ABSTRACT 
 
Haemodialysis is a lifeline therapy for patients with end stage renal disease. A critical 
factor in the survival of renal dialysis patients is the surgical creation of vascular 
access and international guidelines recommend arteriovenous fistulas as the gold 
standard of vascular access for haemodialysis. Despite this, AVFs have been 
associated with high failure rates. Although risk factors for AVF failure have been 
identified, their utility for predicting AVF failure through predictive models remains 
unclear. The objectives of this review are to systematically and critically assess the 
methodology and reporting of studies developing prognostic predictive models for 
AVF outcomes and assess them for suitability in clinical practice. 
Electronic databases were searched for studies reporting prognostic predictive 
models for AVF outcomes. Dual review was conducted to identify studies that 
reported on the development or validation of a model constructed to predict AVF 
outcome following creation. Data was extracted on study characteristics, risk 
predictors, statistical methodology, type of model as well as validation process. We 
included 4 different studies reporting five different predictive models. Parameters 
identified that were common to all scoring system were age and cardiovascular 
disease. 
This review has found a small number of predictive models in vascular access. The 
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3.2 INTRODUCTION 
 
Predictive analytics has allowed for the development of accurate, patient-specific, 
predictive models that can aid in clinical decision-making. Predictive models can 
either be diagnostic or prognostic and are tools that combine multiple predictors to 
obtain a risk or probability. They are becoming increasingly described in the medical 
literature and used in clinical practice. These models have considerable potential to 
contribute to the decision-making process regarding the management of a patient. 
Typically, they combine several clinical, investigational or patient related measures 
to calculate the likelihood of an outcome. 
Haemodialysis (HD) is a life preserving therapy for patients with end stage renal 
disease (ESRD). It is estimated that over 1.5 million patients receive regular HD 
treatment worldwide with the number growing at a rate of around 7% per year 
(Grassmann et al, 2005). A critical factor in the survival of renal dialysis patients is 
the surgical creation of vascular access and international guidelines recommend 
arteriovenous fistulas (AVF) as the gold standard of vascular access for HD 
(Vascular Access 2006 Work Group, 2006; Tordoir et al, 2007). Unfortunately, AVFs 
have been associated with high failure rates, being reported at 30 to 50% 
predominately due to aggressive pathological process termed venous intimal 
hyperplasia (VIH) (Nikam et al, 2012; Al-Jaishi et al, 2014). Numerous factors have 
been described as having an effect on the success rate and therefore a prognostic 
predictive model would be extremely important in planning in clinical practice for 
example guiding decisions on the site of the AVF (Smith, Gohil and Chetter, 2012). 
Existing reviews of prediction models in other diseases have shown that model 
design is critical and many models are poorly developed with weaknesses in their 
	   63 
methodology, validation and reporting (Collins et al, 2013). 
The objectives of our review are to systematically and critically assess the 
methodology and reporting of studies developing prognostic predictive models for 
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3.3 METHOD 
 
Searches of Pubmed central, Ovid Medline and Ovid Embase were performed using 
the combination of the following search terms: haemodialysis, haemofiltration or 
renal failure with vascular access, arteriovenous fistula or arteriovenous shunt in 
addition to the Haynes tool for finding prognostic prediction models to identify 
suitable published articles. In addition, the references cited in selected articles were 
reviewed for any further relevant available studies as well as our personal reference 
list. Articles were not restricted to any language and searches were carried out up to 
31st May 2015. Grey literature was not searched or included. The systematic review 
was performed in accordance with the PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) guidelines (Moher et al, 2009). 
Articles were included if they aimed to develop a multivariable prognostic predictive 
model for AVF maturation or patency outcomes. Articles were excluded if they did 
not develop a new model or the outcome was different from the inclusion criteria. 
Two reviewers (J.A. and D.M.) independently identified articles and screened them 
for inclusion.  Disagreements were solved by consensus between authors. Where 
this was not possible, a 3rd opinion (N.I) was sought. Eligible articles were used to 
develop a potential prognostic assessment tool for predicting patency of 
arteriovenous fistula at 1-year. Studies that assess causal effect of a predictor(s) 
without modelling were excluded. 
From each study, we extracted data on study design, population, outcome definition, 
setting, demographics, the number of patients included, the number of variables 
tested as predictors, model development and evaluation, the type of statistical 
model, using a data extraction sheet. Each study underwent assessment using the 
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TRIPOD (Transparent reporting of a multivariable prediction model for individual 
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3.4 RESULTS 
 
A total of 1378 articles and abstracts were identified using our search strategy. After 
screening the contents of the abstract, 16 full text articles underwent assessment for 
eligibility and quality inspection of methodology. (Figure 3.1)  Following the 
assessment, 4 articles were found to be eligible for the review. (Table 3.1) One 
paper proposed two different models and therefore a total of five models have been 
included in our study. Three models were developed using North American data from 
Canada (Lok et al, 2006) and United States (Feldman et al, 2003) and the other two 
models were European from the United Kingdom (12,13). Of note, the two British 
papers only focused on one type of AVF each (radiocephalic & snuff box) (Twine et 
al, 2012; Bosanquet et al, 2015). 
 
Figure 3.1: Flowsheet describing the results of the search strategy with inclusion 
and exclusions following screening stages  
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Feldman10 Lok11 Twine12 Bosanquet13 
Title  X X X 
Abstract X X X X 
Background  X X X 
Source of data X X X X 
Participants X X X X 
Outcome X X  X 
Predictors X X X X 
Sample size X X X X 
Missing data X X X  
Statistical analysis X X X X 
Risk groups  X   
Development/validation X X   
Participitants X X   
Model development X X X X 
Model specification X X X X 
Model performance X X   
Model updating     
Limitations X X  X 
Interpretation X X X X 
Implications X X X X 
Supplementary 
information 
   X 
Funding X X X X 
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The number of participants included in the development of the prediction models was 
clearly reported in all four studies, ranging from 218 to 422 patients. (table 3.2) The 
prognostic predictive models included a median of five risk predictors. The most 
commonly identified risk predictors included age, venous diameter and CVD. Three 
models used multivariable regression model whilst the other two models used a 
series of separate univariable cox regression analyses. All studies clearly identified 
the type of statistical method that they used to derive the prediction model, two were 
derived using a Cox proportional hazards model (Twine et al, 2012; Bosanquet et al, 
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Table 3.2: Summary table for included predictive models 
 
All five studies claimed to have carried out some form of evaluation of the prediction 
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model. Three models (Feldman et al 2003, Lok et al, 2006) (60%) conducted an 
internal validation of the prediction model with bootstrapping, with one of them also 
using an internal cross validation and external validation (Lok et al, 2006), In our 
opinion two studies did not sufficiently assess their models to validate them. (Twine 
et al, 2012; Bosanquet et al, 2015) 
Three studies (Lok et al, 2006; Twine et al, 2012; Bosanquet et al, 2015) (60%) 
derived simplified scoring systems from the risk prediction models. One study (Lok et 
al, 2006) derived a simple points system by rounding odds ratios to the nearest 
integer, whereby the resulting score would be a simple summation of the integers. 
One study (Twine et al, 2012) derived a simple scoring system by giving an integer 
of 1 for all significant variables however they did not actually use the hazard ratios 
from the cox model. The second study (Bosanquet et al, 2015) used a similar simple 
method, however decided to give two significant variables an integer of 2 due to their 
higher hazards ratio. 
Parameters identified that were common to all scoring system were age and CVD 
(cardiovascular disease). Recent studies have confirmed both age and CVD as a 
risk factor in VA outcomes which supports both as potential prognostic markers 
(McGrogan et al, 2015) 
Previous access was identified as a risk factor in two studies and specifically 
contralateral previous access. Venous diameter, a major factor in access planning 
was only noted in three models although studies assessing outcome using vein size 
less than a pre-defined threshold  (e.g. <2mm cephalic vein at wrist) show a strong 
correlation with failure (Smith, Gohil and Chetter, 2012). 
Dialysis dependency and BP was noted in two studies. Whilst studies subdividing 
patients into pre-dialysis and post dialysis AVF formation show better outcomes for 
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the former this may be confounded by multiple factors such as previous access 
attempts, central venous catheters, uraemia and overall clinical co-mordidity (Smith, 
Gohil and Chetter, 2012).  
In access naïve patients AVF outcome was no different than in patients who had 
already started dialysis although in patients where access was created on the 
ipsilateral side as a previous CVC had worse outcomes. This is consistent with 
previous access being a parameter. 
Ethnicity which has previously shown to affect outcome was only used in one study 
may reflect the low level of ethnic diversity in the studies rather than a true reflection 
of ethnicity as a risk (Lok et al, 2006) 
Pre –existing disease such as diabetes was only a risk in one model although other 
markers of arterial disease (previous cerebrovascular accident /previous lower limb 
angioplasty/peripheral vascular disease) were used. The contribution of arterial 
factors to AVF outcome is poorly defined and more accurate measures may be 
required to enable inclusion in prognostic models. 
One model used absent intra-operative thrill as a strong, but not unexpected marker 
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3.5 DISCUSSION 
 
Haemodialysis is a lifeline for end stage renal failure patients with vascular access 
being a major component of survival. Arteriovenous fistulas have been described as 
the gold standard due to its potential long-term patency, decreased rate of 
complications such as infection and overall survival benefit. (Dhingra et al, 2001) 
Despite this a major limitation of AVFs is the need for the vein to mature to a size 
large enough to be needled for haemodialysis. A number of factors have been 
associated with failure of maturation and this has been described widely in the 
current literature.(Smith, Gohil and Chetter, 2012) These include both patient and 
surgical variables. 
In the general medical literature, scoring systems and predictive models have been 
widely recognized as useful tools in stratifying patients and predicting outcomes in 
cohorts of patients. In vascular access, the ability to predict successful maturation, or 
high risk of failure to mature may allow tailoring of clinical practice to individual 
patients and allow better planning of procedure and improved success. In common 
with many areas of vascular access where the current literature has little evidence 
there is a lack of available data on predictive models and this review could only find 
four eligible studies with a total of five models being described. This is a limitation to 
this review, although it does highlight a key area for future research. Only one paper 
was found to attempt to validate the available models, it would suggest that these 
are not widely used in clinical practice (Lilly et al, 2012). The lack of demonstration of 
validation and performance evaluation of these models on new populations makes it 
impossible to recommend these models. Further testing and validation by a different 
group of investigators in different patient cohorts is necessary. More advanced 
statistical approaches such as boot strapping to internally validate the predictive 
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model may be used. 
A weakness of comparing these models is the heterogeneity of outcomes that were 
used in the available models in particular AVF maturation, AVF non-maturation or 
AVF patency. This is a typical problem in studies of vascular access as different and 
often non-standardized outcomes are commonly described in different studies 
making comparison challenging and recommendations for standard outcome 
measures is mandated (Sidawy et al, 2002) 
The number of patients involved in the modelling process in the identified studies 
(n=218 to 422) compares poorly to available models on other topics such as end 
stage renal failure where numerous models used over 5000 patients (Collins et al, 
2013). Compared to models used in other topics, those available to this review use 
few variables. The results of haemodialysis fistula maturation study (Dember et al, 
2014) will hopefully yield more data for predictive modelling with a higher number of 
patients and potentially more predictive variables.  
In conclusion this review has found a small number of predictive models in vascular 
access. The disparity between each study limits the development of a unified 
predictive model and therefore we recommend more research is required in this field. 
The utility of an accurate well-designed predictive model, which could be applicable 
to a clinical setting, would provide benefit in the planning and tailoring of vascular 












Validation study of the use of a portable 
infrared thermal imaging camera for 
temperature measurement by comparison to 
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4.1 ABSTRACT 
This study was designed to compare the temperature readings obtained from a 
newly available portable infrared thermal imaging camera (FLIR ONE - FLIR 
Systems Inc., Wilsonville, Oregon, USA) with more standard methods of 
thermometry.  
Infrared thermal imaging was initially compared and found to correlate very well with 
both thermocouple and standard thermometer in a body of water with a changing 
temperature. It was subsequently compared and found to correlate well with both 
thermocouple and thermistor on measuring skin temperature.  
In conclusion the results of this study confirms that the use of infrared thermal 
imaging is a valid, non-invasive and user friendly method of measuring skin 
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4.2 INTRODUCTION 
The relationship between high temperature and illness was first described in 
cuneiform tablets from Mesopotamia over 3 millenniums ago. However it was not 
until the renaissance that scientists started to look into ways to measure 
temperature. In 1592 Galileo Galilei invented the first documented device to show 
changes in temperature, a thermoscope (Anbar, Gratt and Hong, 1998). A 
thermoscope could show differences in temperature, allowing observers to know if 
something was getting hotter or colder. However, the thermoscope could not provide 
an exact temperature reading as there was no numerical scale. A German physicist 
Daniel Gabriel Fahrenheit invented both the mercury and the alcohol thermometer at 
the beginning of the 18th century (Haller, 1985). Fahrenheit's mercury thermometer 
consisted of a capillary tube filled with mercury. The mercury expands or contracts 
as the temperature rises or falls. Alongside his inventions, he also described a 
temperature scale which has the freezing point of water at 32 degrees Fahrenheit 
(°F) and the boiling point at 212 °F. Soon after Fahrenheit, a Swedish astronomer 
Anders Celsius came out with a different type of temperature scale, which is today 
referred as the Celsius scale (Pearce, 2002). The original scale set 0°C as the 
boiling point of water and 100°C as the freezing point, but he flipped it around soon 
after inventing the scale. The term Celsius was adopted in 1948 by an international 
conference on weights and measures and is the preferred scale internationally, apart 
from the United States where Fahrenheit is still commonly used (Stimson, 1949). 
This puts the boiling and freezing points of water exactly at 100 degrees apart, 
compared to 180 in the Fahrenheit scale. This is why it is sometimes referred to as 
the centigrade scale. 
Thomas Seebeck, a german physicist, discovered in 1821 that a magnetic field can 
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be observed when there is a temperature difference between the joints of two 
different metals (Velmre, 2007). The magnetic field he discovered was later shown to 
be due to thermo-electric current, which can be used to measure temperature. This 
technique, thermocouple, was found to be less easy to use than thermometers but 
more accurate especially at extreme temperatures. There are also potential 
limitations to thermocouples such as calibration, contact reliability and effect of it on 
skin temperature (Harper Smith et al, 2010). 
Thermistors are based on a piece of ceramic with a known resistance that fluctuates 
with temperature (Moran and Mendal, 2002). Depending on its size, the thermistor 
usually has a longer response time compared to thermocouples. Similarly to 
thermocouples, they have limitations such as the influence of shape and contact 
pressure and the cover to hold the sensor onto the skin (Harper Smith et al, 2010). 
This study was designed to compare the temperature readings obtained from a 
newly available portable infrared thermal imaging (FLIR ONE - FLIR Systems Inc., 
Wilsonville, Oregon, USA) with more standard thermometry. This was carried out to 
assess the suitability and efficacy of the product prior to its use in a clinical setting. 
Infrared thermal imaging cameras have previously been used in clinical context but 
these were complex to use and large in size. Technical advances in both software 
and hardware have improved dramatically over the last decade. Today’s IRTI 
cameras are easy to use, cost effective and considerably more portable. However 








Infrared thermal imaging camera 
The FLIR ONE (FLIR Systems Inc., Wilsonville, Oregon, USA) portable infrared 
thermal imaging camera was used for our study. The thermal camera was kept 
perpendicular to the plane of acquisition as angles of measurement of up to 20 
degrees have a negligible effect on the acquired thermographic temperatures. The 
camera takes full spectrum images where each image pixel acts as a spot measure 
of temperature, which is directly proportional to the thermal energy emitted by that 
site. Subsequent analysis using the accompanying FLIR software for Mac OS X 




For thermometry, we used two different probes to assess temperature. A standard 
thermometer was used for assessment. It is a tall, narrow glass column with a 
constant cross-sectional area, which contains thermometric liquid (red spirit). As the 
temperature of the thermometric liquid in a thermometer increases, its volume 
increases and the increase in volume is proportional to the increase in temperature. 
A digital thermometer was also used for surface thermometry. It is based on K-type 
thermocouple sensor which is a device consisting of two conductors that contact 
each other. A thermocouple produces a voltage when the temperature of one of the 
contact points differs from the temperature of another, in a process known as the 
thermoelectric effect. 
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Procedure 
Testing was performed in the same examination room at a temperature of 20°C 
which was monitored using a calibrated thermometer. A standard liquid thermometer 
and a thermocouple sensor were placed in a bowl full of water. In the first test, 
boiling water was poured into the bowl and temperature readings were taken at 
regular intervals using both types of thermometry. The intervals were determined by 
temperature change in the liquid thermometer (5 degree decrease intervals). In the 
second test, freezing water was poured into the bowl and temperature readings were 
taken at regular intervals using both types of thermometry. The intervals were 
determined by temperature change in the liquid thermometer (2.5 degree increase 
intervals). Infrared thermal imaging were taken at each interval. 
 
Analyses 
Infrared thermal imaging temperature measurements were obtained using the FLIR 
software and these were recorded on an excel spreadsheet alongside standard 
thermometer and thermocouple temperature measurements. The data recorded was 
then analysed statistically using simple linear regressions, to measure the strength of 
the relation between measurements made by the infrared thermal imaging camera 
and those made using the different types of thermometry. 
 
Experiment 2 
Infrared thermal imaging camera 
The FLIR ONE (FLIR Systems Inc., Wilsonville, Oregon, USA) portable infrared 
thermal imaging camera was used for our study. The thermal camera was kept 
perpendicular to the plane of acquisition as angles of measurement of up to 20 
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degrees have a negligible effect on the acquired thermographic temperatures. The 
camera takes full colour images where each image pixel acts as a spot measure of 
temperature, which is directly proportional to the thermal energy emitted by that site. 
Subsequent analysis using the accompanying FLIR software for Mac OS X allows 
measurement of spot temperatures or mean temperatures over selectable area.  
 
Skin thermometry 
For thermometry, we used two different probes to assess skin temperatures. A 
Philips skin surface probe (21078A) was used with Philips V26C monitoring system. 
The temperature measurement is based on a thermistor whose resistance is 
inversely proportional to its temperature. By measuring the thermistor’s resistance, 
its temperature can be calculated. The resistance of the thermistor is measured by 
passing a current through it and measuring the voltage developed across it. A digital 
thermometer was also used for surface thermometry. It is based on K-type 
thermocouple sensor which is a device consisting of two conductors that contact 
each other. A thermocouple produces a voltage when the temperature of one of the 




A total of ten volunteers (four females, six males) participated in a series of skin 
temperature measurement. All were healthy young adults aged between 21 and 32 
years of age (mean: 24.2y) and were right handed. All gave informed consent to 
participate in the study, which was approved by the University of Birmingham (ERN: 
15-0890). 
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Procedure 
Subjects were seated in a quiet environment. Both hands were rested on a specially 
designed pillow to allow resting of the arms. The volunteers were allowed to 
acclimatize to the environment and room temperature for a period of five minutes. 
Testing was performed in the same examination room at a temperature of 20°C 
which was monitored using a calibrated thermometer. The areas assessed for skin 
temperature were the palms and forearms bilaterally. Participants were also asked to 
avoid using hand cream, moisturiser or other cosmetics that could affect the 
thermography.  
A spot was marked on each area of interest. Infrared thermal images were taken of 
both palms and forearms. Subsequently the skin temperature probes were attached 
to the skin of each area on the mark in turn: left palm, left forearm, right palm and 
right forearm. These different sites were chosen to assess the applicability of the 
measurement methods to areas where vascular access surgery would take place. 




Infrared thermal imaging temperature measurements of the marked spots were 
obtained using the FLIR software and these were recorded on an excel spreadsheet 
alongside thermistor and thermocouple temperature measurements. The data 
recorded was then analysed statistically using simple linear regressions, to measure 
the strength of the relation between measurements made by the infrared thermal 
imaging camera and those made using the different types of skin thermometry. 
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4.4 RESULTS 
Experiment 1 
This experiment was designed as to avoid the limitations of contact pressure and 
reliability as the probes were fully immersed in the water. Infrared thermal imaging 
was found to correlate very well with both standard thermometer and thermocouple. 
In the boiling water test, IRTI was found to have a pearson correlation coefficient r 
value of 0.99 with both (Figure 4.1), P-value <0.05. Similarly in the freezing test, IRTI 
was also found to have a pearson correlation coefficient r value of 0.99 with both 
(figure 4.2), P-value <0.05. 
 
Figure 4.1: Comparison of infrared thermal imaging with both thermocouple and 
standard thermometer during the boiling water test 
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Figure 4.2: Comparison of infrared thermal imaging with both thermocouple and 
standard thermometer during the freezing water test 
 
Experiment 2 
To avoid potential errors in methodology by multiple researchers, a single researcher 
collected the data using a consistent methodology. The procedure was designed to 
measure the emitted surface body heat of the volunteer at multiple anatomical 
points. In the ten healthy volunteers, each thermometry device took 40 temperature 
readings. IRTI was found to correlate with both thermocouple and thermistor. 
Compared to thermocouple IRTI had a pearson correlation coefficient r value of 0.79 
and 0.84 when compared to thermistor (Figure 4.3), P-value <0.05.  
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Figure 4.3: Comparison of infrared thermal imaging with both thermocouple and 
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4.5 DISCUSSION 
The main finding of the current study was a positive correlation between infrared 
thermal imaging and more traditional methods of measuring temperature. In 
experiment 1, we showed that IRTI had near perfect correlation with both 
thermometer and thermocouple when measuring the temperature of a body of water. 
The temperature from IRTI was slightly lower when the water was cooling down from 
a boiling temperature as it represented the surface whilst the other two methods 
were immersed in the water and therefore representing the core temperature. 
The relationship between core body temperature and peripheral skin temperature is 
complex and varies both within and between subjects. However experiment 2 
demonstrated that infrared thermal imaging can reliably reflect skin temperature. 
There was a positive correlation between infrared thermal imaging and both 
thermocouple and thermistor. The temperature from IRTI was slightly higher than the 
other two methods of thermometry. This could be due to a margin of error with the 
traditional methods in view of contact pressure limitations. 
In conclusion the results of this study confirms that the use of infrared thermal 
imaging is a valid, reliable and user friendly method of measuring skin temperature in 












Analysis of infrared thermal imaging as a 
marker of tissue perfusion: Vascular occlusion 
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5.1 ABSTRACT 
 
The use of infrared thermal imaging to diagnose circulatory problems in the hands is 
based upon the assumption that a change in skin temperature can be related to a 
change in skin blood flow and the vascular supply is equal in both upper limbs. In 
this study 30 healthy volunteers were exposed to a 2 min vascular occlusion test. 
The resultant reactive hyperaemia with associated skin erythema was assessed with 
Infrared thermal imaging (IRTI) and near infrared spectroscopy (NIRS) to measure 
palmar temperatures and mixed arteriovenous oxygenation of both occluded and 
non occluded arms. We found IRTI to be a useful tool in quantifying reactive 
hyperaemia. Interestingly we also found that there was an increase in palmar 
temperature on the non-occluded side, which would suggest a neurovascular 
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5.2 INTRODUCTION 
 
Endothelial dysfunction has been described as the inability of the artery to sufficiently 
dilate in response to an appropriate endothelial stimulus. It can be assessed by the 
measurement of flow-mediated dilatation (FMD) of the brachial artery after occlusion 
of the blood flow. It is thought that the main mechanism inducing FMD is an increase 
in shear stress, which subsequently leads to a release of nitric oxide from the 
endothelium (Betik, Luckham and Johnson, 2004). The released nitric oxide causes 
blood vessel dilatation (Betik, Luckham and Johnson, 2004). FMD is assessed in a 
noninvasive manner using high-resolution ultrasound of the brachial artery and has 
been proven to be a useful clinical tool to assess endothelial dysfunction, which in 
turn is a predictor of cardiovascular disease (Green et al, 2011). However, FMD is 
operator dependent, technically challenging and requires extensive training 
(Flammer et al, 2012). FMD is also only measured on one arm. Therefore it is likely 
that systemic haemodynamics, such as those resulting from alterations in the 
autonomous nervous system tone, are not accounted for.  
Infrared thermal imaging (IRTI) has been used for several decades to monitor 
cutaneous temperature distribution (Terminology Commission of European 
Association of Thermology, 1978). The technology behind infrared thermal imaging 
has developed considerably since its introduction in the mid 20th century. Technical 
advances in both software and hardware have improved dramatically over this time. 
Today’s IRTI cameras are reliable, accurate, cost effective and considerably more 
portable than previously (Fernandes et al, 2012; Vargas et al, 2009). Endothelium-
mediated changes in tone leading to dilatation after occlusion of the brachial artery 
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are reflected with a hyperaemic response distally. This response should result in a 
change of cutaneous temperature of the hand.  
Infrared light has the unique ability to penetrate beyond the skin into deeper tissues. 
Equally, infrared light absorption by haemoglobin and myoglobin is relatively low 
allowing a significant amount of light to pass through tissues. This relative 
transparency of infrared light is utilised by near infrared spectroscopy (NIRS) 
(Lipcsey, Woinarski and Bellomo, 2012). It can measure tissue oxygenation by the 
use of adhesive pads, which emit a near infrared light at two specific wavelengths 
that penetrate the tissue allowing the receiver to pick up the amount of light passing 
through the tissue (Boushel and Piantadosi, 2000; Creteur, 2008). This allows 
differentiation of oxygenated and deoxygenated haemoglobin measured in pulsatile 
and nonpulsatile blood contained within venous, arterial and capillary vessels 
(Ferrari, Mottola and Quaresima, 2004). This noninvasive technique can be 
performed at the bedside and provides accurate tissue oxygen saturation readings. 
In this study, we aimed to investigate the use of infrared thermal imaging in 
assessing changes in cutaneous temperature of both hands following a vascular 
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5.3 METHODS 
 
This study was done at the University Hospital Birmingham and received full ethical 
approval from the University of Birmingham (ERN: 15-0890). Written informed 
consent was obtained from all healthy volunteers. 
 
Infrared thermal Imaging 
Both hands were imaged at the same time with a portable thermal camera (FLIR 
ONE, FLIR Systems Inc., Wilsonville, Oregon, USA). Images were taken at 15 
second intervals for a total of five minutes (1 minute rest period, 2 minutes occlusion 
period and 2 minutes reperfusion period). Thermal images were subsequently 
processed to extract mean temperature of the palm for both hands at each time 
interval (Figure 5.1). Measurements on the non-occluded hand were used to control 
for concurrent non-endothelium dependent changes in vascular tone. 
 
 
Figure 5.1: Infrared Thermal Imaging of both hands 
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Near infrared spectroscopy 
NIRS was measured using the INVOSTM cerebral/somatic oximeter using an adult 
probe to the thenar eminence of both the dominant and non-dominant arms. This 
gives a non-invasive real time measurement of tissue oxygen saturation. The sensor 
assesses oxygen saturations in both the venous and arterial system in a 3:1 ratio to 
yield a result. Measurements were recorded at 15 seconds interval for a total of five 
minutes (1 minute rest period, 2 minutes occlusion period and 2 minutes reperfusion 
period). The minimal reading achieved is 15% and maximum is 95% for the machine.   
 
Vascular Occlusion Test 
Subjects were seated in a quiet environment. Both hands were rested on a specially 
designed pillow to allow resting of the arms (Figure 5.2). The volunteers were 
allowed to acclimatize to the environment and room temperature for a period of five 
minutes. An initial manual blood pressure and heart rate measurements were taken 
on the non-dominant arm. Following a rest period, the sphygmomanometer was then 
rapidly inflated until 30 mmHg above the systolic pressure and kept inflated for a two 
minute period. The cuff was then released to allow reperfusion. 
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Figure 5.2: Illustration showing the setting for the vascular occlusion test 
 
Statistical Analysis 
Mean palmar temperature was calculated for both occluded and non-occluded. All 
temperature measurements were taken in degree celcius. Data was compared using 
paired Student's t-test (Zimmerman and Donald, 1997). Results were expressed as a 
mean. Statistical significance was considered at a probability of p < 0.05. Statistical 
analyses were performed using SPSS. 
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5.4  RESULTS 
 
Thirty healthy volunteers were included in the initial study. The mean age was 33.8y 
(SD:±8.6). Clinical, thermal and haemodynamic characteristics of the volunteer 
cohort are described in table 5.1. At baseline there was a significant difference 
between mean dominant and non-dominant hand temperatures (p-value<0.05) with 
the dominant side being warmer. 
 
	  
Characteristics	   Healthy	  volunteer	  cohort	  
N=30	  
Mean	  Age	   33.8	  ±	  8.6	  
Sex	   12M:18F	  
Ethnicity	   Caucasian	  66%	  
Asian	  20%	  
Other	  14%	  
Smokers	   8	  
Non	  dominant	  hand	   5R:25L	  
SBP	   119±8	  
DBP	   74±7	  
MAP	   89±6	  
HR	   74±9	  
Mean	  dominant	  hand	  
temperature	  
32.6	  degrees	  





Table 5.1 Volunteer demographics, haemodynamic and thermal characteristics of 
the 30 healthy volunteers for the vascular occlusion test 
 
Mean temperature of both hands at the different time point of the study are described 
in Figure 5.3, blood pressure cuff was inflated at time point 4 and released at time 
point 12. Typical IRTI changes seen at the different periods of the study are 
described in figure 5.4. Once the blood pressure cuff was inflated, the occluded side 
temperature began to drop. Interestingly the mean temperature of the non-occluded 
	   94 
side began to rise significantly as the vascular occlusion was initiated (p-value<0.05) 
and this rise was enhanced after the cuff was released (p-value<0.05). On the 
occluded side, we noted a sharp significant rise in hand temperature following 
release of the occlusion, consistent with a reactive hyperaemic response (p-
value<0.05). The changes in mean temperature at different time points of both hands 
are described in table 5.2. 
 
Experimental times Mean temperature (95% CI):  
occluded hand 
Mean temperature (95% CI):  
non occluded hand 
Time point 1:  
rest period 
32.3 ±1.3 32.6 ±1.3 
Time point 13:  
peak occlusion period 
31.9 ±1.2 33 ±1.3 
Time point 21:  
peak reperfusion period 
33.5 ±1.3 33.7 ±1.4 
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Figure 5.3: Time course of mean changes in palmar temperatures before, during and 
after the vascular occlusion test for both occluded and non-occluded arms 
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Figure 5.4: Typical thermal changes seen during the three different periods of the 
vascular occlusion test 
 
Following preliminary assessment of the IRTI results, a subset of the healthy 
volunteers (n=10) underwent additional INVOS assessment during the vascular 
occlusion test. At baseline there was a significant difference between mean 
dominant and non-dominant tissue oxygen saturation (StO2) (p-value<0.05) with the 
dominant side being higher. Mean StO2 of both hands at the different time point of 
the study are described in Figure 5.5, blood pressure cuff was inflated at time point 4 
and released at time point 12. Once the blood pressure cuff was inflated, the 
occluded side StO2 began to drop as expected (p-value<0.05). Interestingly the 
mean StO2 of the non-occluded side began to rise as the vascular occlusion was 
initiated (p-value<0.05) and this rise continued after the cuff was released (p-
value<0.05). On the occluded side, we noted a sharp significant rise in StO2 
following release of the occlusion (p-value<0.05). 
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Figure 5.5: Time course of mean changes in tissue oxygenation before, during and 
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5.5 DISCUSSION 
 
The principal finding of this study is that infrared thermal imaging can be used to 
quantify reactive hyperaemia following a vascular occlusion test. In addition IRTI can 
also show clearly those changes through the images taken at different time points. 
As expected, a vascular occlusion test leads to a decrease in palmar hand 
temperature in the occluded side. This is due to a lack of blood perfusion of distal 
tissues. We assessed palmar temperature which is the warmest part of the hand and 
therefore we expect this drop in temperature to be even more emphasised in the 
most distal parts such as the tip of the fingers. The release of the blood pressure cuff 
led to a reactive hyperaemic reponse. This response has been investigated in the 
past and is believed to be caused by nitric oxide release from localised vascular 
endothelium. This response has been measured with flow mediated dilatation and 
has been shown to be a good assessment of endothelium function. This in turn has 
been a clinically useful tool in the prediction of cardiovascular events. Therefore IRTI 
might also be a useful measure of endothelium function as it can quantify reactive 
hyperaemia. However we would require large studies with concurrent FMD 
measurements to definitively prove this. Possible study limitations include the 2-
minute cuff inflation compared to the traditional 5-minute protocol for vascular 
function assessment. However, an excellent correlation of vascular function between 
2-minute and 5-minute arm cuff occlusions, has been demonstrated in the literature 
(Gul et al, 2009; Yvonne-Tee, 2008). 
Interestingly we found a significant change in temperature of the contralateral side 
during both occlusion and reperfusion periods. To our knowledge, this increase in 
temperature has only been described in one other study in the literature.12 This rise 
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in palmar temperature is likely due to a neurovascular reactive response mediated 
by the autonomic nervous system leading to vasodilation and therefore an increase 
in blood flow (Ahmadi et al, 2009). In addition, there would also be diversion of blood 
flow from the occluded sided into the non-occluded side during the occlusion period. 
This finding was also confirmed on near infrared spectroscopy as it showed an 
increase in tissue oxygenation on the contralateral side during a vascular occlusion 
test. This finding can correlate with an increase in blood supply to the contralateral 
side. It would be important to confirm those infrared thermal imaging results in a 
larger study with the addition of flow mediated dilatation and near infrared 
spectroscopy. If these results are confirmed in larger studies, it might well question 
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6.1 ABSTRACT  
 
The arteriovenous fistula is the preferred method of long-term haemodialysis. 
However it has been shown to have a substantial rate of maturation failure. The 
formation of an AVF creates haemodynamic changes to blood flow in the arm with 
diversion of blood away from the distal circulation into the low pressure venous 
system, in turn leading to thermal changes distally. In this study we aimed to assess 
the novel use of infrared thermal imaging as a predictor of arteriovenous maturation. 
A prospective cohort study was conducted on 100 consecutive patients who had 
AVF formation from December 2015 to June 2016. Infrared thermal imaging was 
undertaken pre- and post-operatively on the day of surgery to assess thermal 
changes to the arms and assess them as predictors of clinical patency and functional 
maturation. 
For clinical patency, infrared thermal imaging was found to have a positive predictive 
value of 88% and a negative predictive value of 86%. For functional maturation, it 
was found to have a positive predictive value of 84%, a negative predictive value of 
95%. In addition, it was shown to have superiority to the commonly used intra-
operative predictor of thrill as well as other independent pre-operative patient factors.  
Infrared thermal imaging has been found to be a very useful tool in accurately 
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6.2 INTRODUCTION  
 
The arteriovenous fistula (AVF) is the preferred method of long-term haemodialysis 
vascular access, as it has been shown to have better longevity and fewer 
complications than arteriovenous grafts (National Kidney Foundation, 2006). 
However, one of the major setback to AVFs is its substantial rate of failure to mature, 
which has been quoted to be as high as 50% (Dember et al, 2008).  
Over the last few decades, numerous studies have tried to establish an association 
between AVF maturation and both pre-operative and intra-operative factors that will 
make it possible to predict the outcome of a newly created fistula (Farber et al, 
2016). Predictive models based on patients' demographics and those factors have 
been suggested; however they are few in numbers, based on relatively small number 
of patients and associated with complex statistical and validity issues (Al Shakarchi 
et al, 2016c). Therefore currently intra-operative thrill is still the most commonly used 
predictor of AVF maturation.  
The formation of an AVF creates haemodynamic changes to blood flow in the arm 
with diversion of blood away from the distal circulation into the low pressure venous 
system (Inston et al, 2017). Computational fluid dynamics (CFD) simulations have 
shown that immediately after AVF formation, the greater part of the arterial flow 
enters into the vein (81%) and only a smaller part flows through the distal artery 
(19%) toward the hand (Ene-Iordache and Remuzzi, 2012). Previous studies have 
shown that most of those changes occur in the first 24 hours following surgery 
(Yerdel et al, 1997; Lin et al, 1998). It has also been demonstrated in numerous 
studies that higher intra-operative blood flow in the AVF is associated with improved 
rates of maturation (Johnson et al, 1998). Therefore intraoperative blood flow 
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measurement has been proposed as a good predictor of AVF outcome, however it 
might have some accuracy issue as seen by the wide range of cut off values from 
the published literature (Berman et al, 2008; Lin et al, 2008; Saucy et al, 2010).10,11,12 
The post-operative haemodynamic changes causes a reduction in blood flow and 
perfusion distal to the anastamosis, which in turn should lead to a reduction in skin 
temperature until arterial remodeling occurs. This would propose a hypothesis that 
thermal changes, which occur distal to the anastomosis of an AVF, might be 
predictive of subsequent patency and maturation.  
Infrared thermal imaging (IRTI) has been used to study a number of diseases where 
skin temperature can reflect the presence of inflammation in underlying tissues, or 
where blood flow has changed due to a clinical abnormality. IRTI has been shown to 
be equal to or superior to that of the traditionally used skin thermistor thermometry 
(Burnham, McKinley and Vincent, 2006). However the use of this technology was 
restricted to research purposes due to its high cost and complex use. Technical 
advances in both software and hardware have improved IRTI cameras dramatically 
as they are now more accurate, easy to use, and considerably more portable than 
previously providing a potential near patient tool for skin perfusion. The FLIR One 
camera is a lightweight, affordable and easy to connect attachment to a smartphone, 
whilst the provided software allows easy extraction of spot temperatures, which can 
be done directly from the smartphone or from a computer.  
This study aimed to assess the novel use of infrared thermal imaging as a predictor 
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6.3 METHODS  
 
The study was approved by University Hospital Birmingham and the National 
Research Ethics Committee (IRAS project ID: 186081). This was a prospective 
cohort study of consecutive eligible patients with chronic kidney disease. 
Recruitment was undertaken from December 2015 and June 2016 and patients were 
followed up until December 2016. All patients undergoing AVF formation were 
screened for the inclusion criteria and if appropriate, approached to participate in the 
study. All patients gave written informed consent on the day of surgery. 
Inclusion criteria for the study were: consecutive patients undergoing arteriovenous 
fistula formation, aged over 18 years and able to consent. They had already started 
or were expected to progress to treatment with maintenance haemodialysis within 3 
months. Exclusion criteria were: history of ipsilateral upper limb revascularization 
procedure, sympathectomy or complex vascular access procedure (arteriovenous 
graft and redo surgery).  
All patients underwent pre-operative ultrasound mapping to select the most 
appropriate anatomical site dictated by vessel diameters. At our institution, a 
minimum diameter of 2mm for both artery and vein is required for fistula creation. 
Demographic and clinical data were collected including gender, age, cause of end 
stage renal failure, co-morbidities, type of AVF created, pre-operative ultrasound 
results and intra-operative finding including thrill. The presence of thrill was assessed 
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Infrared thermal imaging assessment 
Patients were seated in a quiet environment and were allowed to acclimatize to the 
environment and room temperature. Both hands were placed on a pillow to allow 
resting of the arms. Both arms were imaged at the same time with a portable thermal 
camera (FLIR ONE, FLIR Systems Inc., Wilsonville, Oregon, USA). This was carried 
out pre- and post-operatively within 30 minutes of the surgery (figure 6.1). The 
camera has a temperature sense range of -20° to 120° degrees celcius with an 
accuracy of 0.1°. Thermal images were subsequently processed to extract spot 
temperature at the tip of the middle finger on both hands, as this is the most distal 
part of the hand and should theoretically be the most affected by any haemodynamic 
change in blood flow.  In each case, the measurements of the contralateral side were 
used as control. This is due to skin temperature being variable and inaccurate due to 
environmental factors if assessed as an absolute figure. Therefore, a more accurate 
way to measure skin temperature changes following AVF creation is to look at 
relative difference in temperature between operated and contralateral side before 
and after surgery. The measurements from the operated side were converted into 
relative temperatures by subtracting measurements made on the patient’s 
contralateral side. The changes in relative temperatures from pre- to post-op were 
then calculated from the resulting values. 
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Figure 6.1 – Infrared thermal imaging on the same day before (left image) and after 
creation (right image) of a left brachiocephalic fistula, which matured successfully. 




The primary outcome measure for the study was AVF clinical patency. Post-
operative fistula assessment was performed at 6 weeks after creation, to evaluate 
the status of the fistula. Clinical patency was determined with ultrasound criteria of 
AVF diameter  >  6 mm and clinical assessment by an experienced clinician of the 
presence of a strong thrill at the anastomosis and suitability for needling. Clinical 
assessments done at 6 to 8 weeks post creation have been shown to predict the 
ability of the AVF to support dialysis with a mature functional AVF (Robbin et al, 
2002). The secondary outcome measure was functional maturation as defined by 
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Statistical analysis 
Initially, comparisons were made between those patients whose fistulas did and did 
not mature. Continuous variables were reported as mean±SD, with p-values from 
independent samples t-tests, with Fisher’s exact tests for nominal factors. 
Continuous factors that were found to be significantly associated with fistula 
maturation were further assessed using ROC curves, and the optimal cut-off values 
identified. Performance measures were then calculated for the predictive accuracy at 
these cut-off values, as well as for the nominal variables. 
A multivariable binary logistic regression model was then produced, to test whether 
combining factors together into a risk score could give more accurate prediction of 
fistula maturation than was achieved by individual factors. A forwards stepwise 
approach was used to select factors for inclusion. 
All analyses were performed using IBM SPSS 22 (IBM Corp. Armonk, NY), with 
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6.4 RESULTS   
 
Data were available for 100 consecutive patients with no patients being excluded. No 
patients received any intervention on their fistula to aid maturation. In two cases, the 
outcome of fistula maturation was not available, due to death (n=1) and complication 
leading to ligation (n=1) prior to follow up; hence these patients were excluded from 
further analysis. The remaining patients had a mean age of 60.0±14.9 years, 57% 
were male, and the majority of White (49%) or Asian (37%) ethnicity. Data were 
complete for all variables, with the exception of the pre-operative vein and artery 
diameters, which were not documented for 3 and 10 patients respectively.  
Clinical patency was achieved in 71% (N=70) of cases. 16 patients did not start 
haemodialysis during follow up, therefore functional maturation was attained in 65% 
of patients (53/82). The relationships between clinical patency and a range of pre-
operative factors are reported in Table 6.1. None of the factors relating to patient 
demographics or co-morbidities were found to be significantly associated with fistula 
patency. As expected, AVFs were found to be significantly more likely to be patent in 
patients with upper arm (Brachio-Basilic or Brachio-cephalic) AVFs (p=0.004) and 
those with larger pre-operative artery diameters (p=0.020). Adverse events following 
surgery included two wound infections and one incidence of arteriovenous access 
ischaemic steal (AVAIS).  
The relationship between temperature measurements and fistula clinical patency is 
shown in Table 6.2. For the proximal temperature measurements, no significant 
association was detected between fistula clinical patency and change (p=0.338) in 
relative temperature, therefore no further analysis was carried out. A ROC analysis 
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found the change in relative distal temperature to be a good predictor of clinical 
patency, with an area under the ROC curve (AUROC) of 0.86.  
 
   Patent  
  N No Yes p-Value 
Age (Years) 98 58.6 ± 15.0 60.6 ± 15.0 0.552 
Sex    0.258 
Female 42 9 (21%) 33 (79%)  
Male 56 19 (34%) 37 (66%)  
Ethnicity    0.952 
White 48 13 (27%) 35 (73%)  
Asian 36 11 (31%) 25 (69%)  
Black/Other 14 4 (29%) 10 (71%)  
Dialysis    1.000 
No 64 18 (28%) 46 (72%)  
Yes 34 10 (29%) 24 (71%)  
Diabetes    0.819 
No 60 18 (30%) 42 (70%)  
Yes 38 10 (26%) 28 (74%)  
Hypertension    1.000 
No 14 4 (29%) 10 (71%)  
Yes 84 24 (29%) 60 (71%)  
AVF Side    0.803 
Left 72 20 (28%) 52 (72%)  
Right 26 8 (31%) 18 (69%)  
AVF Type    0.004 
BB 9 0 (0%) 9 (100%)  
BC 64 15 (23%) 49 (77%)  
RC 25 13 (52%) 12 (48%)  
Pre-op Vein Diameter (mm) 95 3.4 ± 0.9 3.7 ± 1.1 0.187 
Pre-op Artery Diameter (mm) 88 3.6 ± 1.1 4.3 ± 1.3 0.020 
Data reported as N (%), with p-values from Fisher’s exact tests, or mean±SD, with p-values from t-
tests, as applicable. Bold p-values are significant at p<0.05 
 








(SE) No Yes p-Value 
Relative Distal Temperature (°C)  
Change in temp. +0.1 ± 0.9 -1.4 ± 1.2 <0.001 0.86 (0.05) 
Relative Proximal Temperature (°C)  
Change in temp. +0.1 ± 1.0 +0.2 ± 0.8 0.338 0.53 (0.07) 
*Data reported as mean±SD, with p-values from t-tests  
**Areas under ROC curves (with standard errors) for the predication of fistula maturation 
Bold values are significant at p<0.05 
 
Table 6.2 – Associations between distal and proximal relative temperatures and 
clinical patency 
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The analysis of relative temperatures found that a reduction in temperature from pre- 
to post-op was significantly associated with both clinical patency and functional 
maturation (p<0.001). The relationship between the change in relative distal 
temperature and clinical patency rate is reported in Figure 6.2, showing an increased 
rate of patency with a greater reduction in distal temperature. For the 22 patients 
whose relative distal temperature remained the same or increased post-operatively, 
only 3 (14%) achieved fistula clinical patency, compared to 88% of the 76 patients 
with a drop in relative temperature (Figure 6.2). 
 
Figure 6.2 – Fistula patency rate by change in relative distal temperature  
 
Analysis on two patient groups, based on the post-operative change in relative distal 
temperature was subsequently performed. Patients where the temperature remained 
the same or warmer, were compared to those where there was a decrease in relative 
temperature. A range of performance measures was calculated, to assess how 
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accurately this factor could predict both clinical patency and functional maturation 
(Table 6.3 and 6.4). For clinical patency, the factor was found to have a positive 
predictive value of 88%, a negative predictive value of 86%, a sensitivity of 96%, and 
specificity of 68%. For functional maturation, the factor was found to have a positive 
predictive value of 84%, a negative predictive value of 95%, a sensitivity of 98%, and 
specificity of 69%. Predictive accuracy was also assessed for the commonly used 
intra-operative predictor of thrill and was found to be much inferior than IRTI. In the 
sub-analysis, IRTI was found to be a good predictor of clinical patency for both upper 
arm and forearm fistulas (Table 6.5). 
 
 
            Patent     
 No Yes Rate Sensitivity Specificity PPV NPV Relative Change in Distal Temperature     Colder Hand 9 67 88% 
96% 68% 88% 86% Same or 
Warmer 19 3 14% 
Thrill      Yes 19 65 77% 93% 32% 77% 64% No 9 5 36% 
	  




 Matured     
 No Yes Rate Sensitivity Specificity PPV NPV Relative Change in Distal Temperature     Colder Hand 9 51 85% 
96% 69% 85% 91% Same or 
Warmer 20 2 9% 
Thrill      Yes 20 50 71% 94% 31% 71% 75% No 9 3 25% 
	  









 Patent     
 No Yes Rate Sensitivity Specificity PPV NPV Relative Change in Distal Temperature  
Upper arm AVF     
Colder Hand 5 56 92% 
97% 66% 92% 83% Same or 
Warmer 10 2 17% 
Relative Change in Distal Temperature 
Forearm AVF      
Colder Hand 4 11 73% 
92% 69% 73% 90% Same or 
Warmer 9 1 10% 
 
Table 6.5 –Performance measures for IRTI depending on fistula type for clinical 
patency 
 
A binary logistic regression model was then produced, in an attempt to identify the 
most predictive combination of these factors. The resulting model (Table 6.6) 
identified a reduced relative distal temperature as the best predictor of fistula 
maturation (odds ratio = 55.6, p<0.001), but also identified pre-operative artery 
diameter >4.3 as a second independent predictor (odds ratio = 6.8, p=0.021). Vein 
diameter was not shown to be a significant independent predictor and this is likely 
due to exclusion of veins with a diameter of less than 2mm. 
 
 
 Factor B* Odds Ratio (95% CI) p-Value 
Colder Hand 4.0 55.6 (10.2 - 304.7) <0.001 
Pre-op Artery Diameter >4.3mm 1.9 6.8 (1.3 - 34.1) 0.021 
Results are from a binary logistic regression model using a forwards stepwise entry procedure, and 
considering all of the factors in Table 3 for inclusion. 
Analysis was based on the N=88 for whom pre-op artery diameters were available. 
*Beta coefficient (i.e. log-odds) 
Bold p-values are significant at p<0.05 
 
Table 6.6 – Binary logistic regression model for the prediction of maturation 
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Dividing the coefficients from the resulting model by two, and rounding to the nearest 
integer meant that a simple risk score could be produced (Table 6.7). This score had 
a marginally improved AUROC over using the relative distal temperature change in 
isolation (0.89 vs. 0.86), with 100% of the 31 patients with the highest score 
achieving fistula maturation compared to 15% of the 15 patients with the lowest 
score. However, due to the relatively small sample size, this score would need to be 







Hand? Score N Matured 
No No 0 13 2 (15%) 
Yes No 1 7 1 (14%) 
No Yes 2 37 28 (76%) 
Yes Yes 3 31 31 (100%) 
AUROC=0.89 (SE=0.04) 
Analysis was based on the N=88 for whom pre-op artery diameters were available. 
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6.5 DISCUSSION 
 
Our findings demonstrate that infrared thermal imaging has a very good predictive 
ability, for both clinical patency and functional maturation. It has shown superiority to 
the commonly used intra-operative predictor of thrill. Comparing our results to the 
published literature on intra-operative flow measurement, IRTI has a better predictive 
value (Table 6.8).  
 





Sensitivity Specificity PPV NPV 





























Forearm 58 67% 75% 91% 38% 
 
Table 6.8 – Comparison of predictive accuracy of intra-operative blood flow and 
infrared thermal imaging 
 
Our study can have a direct impact on clinical practice. The ability to accurately 
predict AVF outcome means that patient post operative follow-up can be individually 
personalised and patient whose AVF is predicted to fail can be monitored more 
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closely. Possible causes of early AVF failure include surgical technique leading to a 
poor inflow and poor vein quality including stenotic lesions. So if an AVF is predicted 
to fail, a fistulogram could be organized with potentially a subsequent interventional 
procedure to treat any lesion and improve blood flow.   
Previous studies have suggested that it takes as long as 10 weeks for an AVF to 
mature (Wilmink et al, 2016). The ability to accurately predict a failure would spare 
patients this long wait. In turn, this might reduce the length of dialysis catheter use, 
which is associated with both morbidity and mortality. For pre-dialysis patients, it 
would potentially increase the chances for them to start dialysis on a fistula. This is 
especially important as we know that there is a poor AVF conversion rate when a 
patient starts haemodialysis on a catheter. 
In our cohort, there was only one incidence of haemodialysis access induced distal 
ischaemia (HAIDI). Interestingly, we found that ten patients had a larger drop in 
distal temperature than the patient who had HAIDI and none of them developed any 
symptoms. This would confirm that the key factor in the development of HAIDI is the 
inability of the arterial system to remodel and compensate for the diversion of blood 
flow (Inston et al, 2017). 
In addition, our study also confirmed that upper arm fistulas matured significantly 
more than forearm fistulas. It has previously been reported that forearm fistulas have 
a higher risk of primary failure and failure to mature than upper arm AVFs (Peterson, 
Barker and Allon, 2008). We also found that a higher arterial diameter was 
significantly correlated with improved fistula maturation rate. This finding is confirmed 
by previous papers showing that pre-operative arterial diameters of radiocephalic 
AVF has been found to be associated inversely with immediate postoperative 
thrombosis and thrombosis up to 1 week after surgery (Wong et al, 1996).  
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In conclusion, infrared thermal imaging has been found to be an accurate and 
clinically useful post-operative tool in predicting AVF outcome. This can, at least, 
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7.1 DISCUSSION 
 
Every arteriovenous fistula has the potential to be the only vascular access a patient 
with end stage renal failure will ever need. It has a lower infection rate compared to 
both arteriovenous graft and tunnelled dialysis catheters. It has also been shown to 
require less interventions to keep it patent than grafts (Bittl J.A., 2010). Unfortunately 
for patients, this potential is not fulfilled often and therefore most patients will 
undergo multiple vascular access procedures during their dialysis lifetime. One of the 
biggest hurdles to achieve a patent long-term arteriovenous fistula is actually the first 
one with the maturation process. Failure to mature has been reported to be as high 
as 50% in some North American papers (Al-Jaishi et al, 2014) but it has traditionally 
been lower in Europe with rates of around 25% (Field M et al, 2016). Therefore it has 
been the most highly researched topic in vascular access.  
Unfortunately to date, no adjuvant medical treatment has been able to improve this. 
A systematic review on this topic showed that the quality of the evidence was low 
due to short follow-up periods, the small number of studies for each comparison, 
heterogeneity between trials and moderate methodological quality of the studies due 
to incomplete reporting (Tanner N.C. and Da Silva A.F., 2016). This is probably due 
to the pathogenesis of non-maturation being poorly understood and therefore no 
clear target for therapy development. 
Therefore until such therapy is available, being able to predict arteriovenous fistula 
maturation is important for the patient pathway as it will allow closer monitoring to 
AVFs at risk of non-maturation. Both venous and arterial diameters have been 
shown to be independent factors of maturation. The literature and our study (chapter 
2) have shown numerous contradictions and therefore few pre-operative or intra-
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operative factors were found to be good independent predictors of maturation 
(Farber A. et al, 2016). Our systematic review on predictive models found a small 
number of predictive models in vascular access. It concluded that the disparity 
between each study limits the development of a unified predictive model and more 
research is required in this field (chapter 3). 
Infrared thermal imaging has been available for decades but recent development in 
technology has made it small, portable and easy to use. We have shown that this 
new available hardware is a valid, accurate and user-friendly mode of measuring 
skin temperature in humans and is comparable to more traditional methods of 
thermometry (Chapter 4). Another principal finding from our thesis is that infrared 
thermal imaging can be used to quantify reactive hyperaemia following a vascular 
occlusion test (Chapter 5). In addition IRTI can also show clearly those changes 
through the images taken at different time points. This is important when assessing 
the quality of new technology to be used clinically, especially in vascular surgery. 
The IRTIVA study (Chapter 6) has also highlighted that a larger decrease in distal 
temperature post operatively correlates with an increased maturation rate. Therefore 
high flow into the vein at the time of surgery is the most important key factor for 
maturation and reduction in neointimal hyperplasia. This is consistent with the 
experience from French surgeons that regional anaesthesia offers improved rates of 
maturation as it results in vasodilation and increased blood flow compared to local 
anaesthesia. This was confirmed in a recently published randomised controlled trial 
showing significant improved rate of AVF patency when regional anaesthesia was 
used (84% vs 62%) (Aitken E. et al, 2016). A North American study investigated 
intraoperative blood flow measurements during AVF formation and found that 
matured fistulas had more than twice the blood flow at time of surgery than the ones 
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which did not mature (Berman SS et al, 2008). It has also recently been shown that 
AVF blood flow rate at day 1 is usually more than 50% of the 6-week blood 
flow rate (Robbin M.L. et al, 2016). Therefore a key component in future vascular 
research research should be to investigate local vasodilating agents, to increase 
blood flow into the vein at time of surgery, which last for the first 24 hours after 
surgery. For that purpose a recently published randomized controlled trial assessed 
the use of GTN transdermal patches in improving AVF outcome but unfortunately it 
did not show any improvement in maturation rate (Field M. et al, 2016). This could be 
due to the more systemic effect of the patches rather than one specifically targeting 
the fistula. Another agent PRT-201, a recombinant human type I pancreatic elastase, 
is currently being investigated to improve vascular access outcomes. In animal 
models, PRT-201 doses have been shown to fragment the majority of elastin in 
blood vessels resulting in a persistent vasodilation (Franano F.N. et al, 2007). The 
substance has been shown to be safe in humans and is awaiting robust results from 
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7.2 CONCLUSIONS 
 
Infrared thermal imaging can be used as noninvasive near patient test and it has 
been shown to be a valid user-friendly method of thermometry. The hypothesis that 
IRTI may be useful in prediction of VA outcomes has been explored in this thesis. It 
is clear that IRTI has a definite role in renal patients with vascular access as it was 
found to be an accurate and clinically useful post-operative tool in predicting AVF 
outcome. In addition, there is great potential for its use in other conditions such as 
peripheral vascular disease. It could be used as a non invasive near patient test in 
monitoring of outcomes following reperfusion interventions, both surgical and 
radiological ones. It might also be used as a predictor of outcome following renal 
transplantation. Therefore this thesis will be followed by research projects 
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